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Abstract	  
	  
Extrinsic	  and	  environmental	  factors	  are	  known	  to	  affect	  the	  transmission	  of	  
arthropod-­‐borne	  viruses	  (arboviruses),	  including	  variations	  in	  the	  arthropod	  vector	  
populations.	  	  Differences	  among	  these	  factors	  have	  been	  associated	  with	  differential	  
transmission	  and	  are	  sometimes	  used	  to	  control	  the	  spread	  of	  an	  arbovirus	  through	  
a	  vertebrate	  population	  in	  an	  effort	  to	  prevent	  or	  disrupt	  an	  outbreak.	  However,	  
diversity	  in	  intrinsic	  viral	  populations,	  such	  as	  genetic	  and	  phenotypic	  variability,	  is	  
not	  often	  accounted	  for	  when	  considering	  alterations	  in	  transmission.	  	  Presented	  in	  
this	  dissertation	  are	  four	  experimental	  studies	  that	  explore	  the	  contribution	  of	  viral	  
intrinsic	  factors,	  especially	  phenotypic	  variability,	  to	  the	  transmission	  potential	  of	  
arboviruses	  as	  judged	  by	  modeling	  parameters	  such	  as	  vectorial	  capacity	  (VC)	  and	  
the	  basic	  reproductive	  number	  (R0).	  	  The	  overall	  hypothesis	  of	  this	  research	  is	  that	  
phenotypic	  differences	  of	  arboviruses	  alter	  the	  transmission	  potential	  of	  these	  
arboviruses	  by	  conferring	  fitness	  advantages	  in	  either	  the	  vector	  or	  the	  vertebrate.	  
Further,	  these	  phenotypic	  differences	  need	  not	  be	  large	  in	  magnitude	  to	  affect	  the	  
relative	  transmission	  potential.	  	  To	  investigate	  this	  hypothesis,	  this	  research	  
determined	  1)	  whether	  intrinsic	  viral	  characteristics	  can	  lead	  to	  differential	  
transmission	  in	  a	  given	  locale,	  2)	  whether	  variability	  of	  viral	  fitness	  in	  the	  mosquito	  
vector	  can	  lead	  to	  significant	  differential	  transmission	  potential,	  3)	  how	  our	  newly	  
formulated	  methods	  from	  our	  preceding	  aim	  could	  aid	  in	  the	  explanation	  of	  a	  
currently	  puzzling	  phenomenon	  in	  the	  field	  of	  arbovirology,	  4)	  whether	  phenotypic	  
differences	  in	  the	  vertebrate	  host	  alters	  the	  potential	  for	  transmission,	  and	  5)	  how	  
	   xii	  
identified	  phenotypic	  differences	  in	  both	  the	  vector	  and	  vertebrate	  hosts	  could	  act	  
synergistically	  or	  antagonistically	  to	  alter	  transmission	  potential	  of	  arboviruses.	  	  
The	  research	  in	  this	  dissertation	  offers	  a	  more	  accurate	  tool	  for	  assessing	  
transmission	  potential	  in	  the	  vector,	  provides	  a	  new	  model	  assessing	  transmission	  
potential	  in	  the	  vertebrate,	  and	  provides	  several	  of	  the	  necessary	  steps	  towards	  a	  
more	  appropriate	  calculation	  of	  R0.	  	  Our	  use	  of	  R0	  based	  on	  dynamic	  phenotypic	  
differences	  provides	  a	  framework	  for	  a	  more	  dynamic	  formulation	  of	  transmission	  
models,	  and	  provides	  an	  accessible	  framework	  for	  output	  validation	  and	  reporting	  




Introduction and Literature Review 
Introduction 
 Arboviruses are arthropod-borne viruses, which require an amplification stage in an 
arthropod to complete the transmission cycles. Most arboviruses are transmitted by mosquitoes 
or ticks, though a few are transmitted by lice, black flies, midges or nest bugs (Kuno and Chang 
2005). Most arboviruses are classified into three main families: Togaviradae, Bunyavirade, 
Flaviviradae (Monath 1988; Weaver and Reisen 2010). Of those arboviruses of medical and 
veterinary importance, the disease manifestations include febrile illnesses, encephalitis and 
encephalomyelitis, and hemorrhagic diseases. Some of these same arboviruses cause no 
symptoms at all (Kuno and Chang 2005). Of specific interest are West Nile virus (WNV), 
dengue virus (DENV), and Chikungunya virus (CHIKV). WNV and DENV are members of the 
genus Flaviviridae, a family of viruses, many of which are medically important (Figure 1.1). 
CHIKV is a member of the Alphavirus genus, family Togaviridae, which a smaller group of 
viruses, but also have medical importance (Figure 1.2) (Schmaljohn and McClain 1996; Kuno 
and Chang 2005). 
 Flaviviruses have an approximately 11kb, positive-sense, single stranded RNA genome. 
The single open reading frame is co- and post-transcriptionally processed into three structural 
(Capsid, preMembrane, Envelope) and seven non-structural genes (NS1, NS2A, NS2B, NS3, 
NS4A, NS4B, NS5) (Brinton 2002). Alphaviruses have a similar genome, with approximately 
12kb, positive-sense, single stranded RNA, which encodes three structural proteins (C, E1, E2) 
and four non-structural proteins (NS1-4). Unlike flaviviruses, alphaviruses have a poly-A tail at 
the 3’ end (Schmaljohn and McClain 1996; Tsetsarkin, Vanlandingham et al. 2007; Solignat, 
Gay et al. 2009).  
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 The primary mechanism believed to mediate the success of arboviral infection 
establishment in the vertebrate host is the anti-viral, type I interferon response (Lobigs, 
Mullbacher et al. 2003; Couderc, Chretien et al. 2008; Tobler, Cameron et al. 2008; Munoz-
Jordan 2010; Lazear, Pinto et al. 2011). Upon inoculation, arboviruses infect the cells that are 
localized to the skin tissue. DENV, WNV and CHIKV are suspected to have a tropism for 
dendritic cells upon initial infection (Palucka 2000; Wu, Grouard-Vogel et al. 2000; Kramer, Li 
et al. 2007; Kyle, Beatty et al. 2007). When the virus infiltrates a cell via endocytosis, Toll-like 
receptors (TLR) such as TLR3 or TLR7 recognize double stranded RNA and set off a cascade of 
signals resulting in the transcription of type I interferon (IFN-α/β). For example, through the 
activation of TLR-3, NFκB and other transcription factors, particularly interferon regulatory 
factor (IRF) 3 and 7 lead to the production of interferon β. IFN β positively feeds back via the 
type I interferon receptor to activate the JAK/STAT pathway, involving IRF7 and IRF 9 
transcription factors for IFN genes. These two cytokines, IFN α and β, are responsible for the 
establishment and maintenance of the anti-viral state in the immune response, a significant factor 
being the production of type II interferon (IFN-γ) (Katze, He et al. 2002; Haller, Kochs et al. 
2006; Partidos, Weger et al. 2011). Other receptors in the cytoplasm, such as RIG-1 and MyD88 
are also responsible for signaling the type I IFN pathway (Kawai and Akira 2006; Gilfoy and 
Mason 2007; Fredericksen, Keller et al. 2008). Downstream interferon-induced proteins, such as 
CXCL10 (IP10), have also been correlated to viral replication and ultimate seroconversion 
(Nightingale, Patkar et al. 2008; Tobler, Cameron et al. 2008). 
 
Arbovirus Transmission 
 Arboviruses usually are maintained through a zoonotic transmission cycles where the 
arbovirus is passed from one or a few main vector species to one or a few main vertebrates  
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Figure 1.1: Flaviviruses. Phylogeny of Flaviviruses from Kuno, et al 2005 [2]. 
 
 
Figure 1.2: Alphaviruses. Simplified phylogeny of alphaviruses generated from E1 analysis 
from Solignat, et al 2009 (Solignat, Gay et al. 2009). 
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1. Viral characteristics, such as better replication in an unusual vertebrate/vector species 
(Weaver and Reisen 2010). A zoonotic disease then leaves the enzootic cycle and spills 
over into an unusual vertebrate population. This spill over can be due to many factors, 
such as, but not limited to: 
2. Unusual vector behavior such as the main vector species expanding its feeding repertoire. 
This can happen if:    
a. The populations of the vertebrate that is the main preference of the vector (such as 
birds for ornithophilic mosquitoes) becomes scarce or  
b. There is encroachment into the habitat of the vector, in which case infection of the 
unusual (ex-zootic) vertebrate host is incidental. 
3. A bridge vector becomes infected and initiates the ex-zootic cycle by preferentially 
feeding on its specific host. 
 A classic example of the first factor is the adaptation of CHIKV virus to Ae. albopictus 
after a mutation caused a single amino acid change in the envelope protein, domain III region. 
This valine to alanine substitution made CHIKV much more fit in Ae. albopictus with 
dissemination rates being earlier and higher. The subsequent outbreak on La Reunion Island in 
2006 was of epidemic proportions, and this strain of CHIKV quickly spread throughout the 
Indian subcontinent and SE Asia, displacing the pre-mutation strain (Tsetsarkin, Vanlandingham 
et al. 2007; Santhosh, Dash et al. 2009; Tsetsarkin, Chen et al. 2011). Another example is the 
similar mutation in WNV, in the envelope domain II, where an alanine to valine substitution 
increased the virus’ fitness in Culex mosquitoes, again increasing dissemination rates as well as 
enabling earlier transmission (Moudy, Meola et al. 2007). Though first isolated in 2001, this 
strain was called WN02. After this mutation, the WN02 strain spread quickly across the western 
United States and has since completely displaced the originally invading NY99 strain (Jerzak, 
Bernard et al. 2005; Snapinn, Holmes et al. 2007; Kramer, Styer et al. 2008).  
 5 
 West Nile virus is an example of the second factor, where the usually ornithophilic but 
ubiquitous Culex mosquitoes take blood from viremic birds and then transmit WNV to people 
and/or horses, both of which are dead end hosts (Kramer, Li et al. 2007; Kutasi, Bakonyi et al. 
2011; Sirbu, Ceianu et al. 2011). In addition, tick-borne Flavivirus  infections (POWV, TBE, 
OMSKV) occur in humans who engage in activities such as hiking where they are in direct 
contact with the tick’s habitat or directly from the small rodent reservoir  (Dobler 2010; Weaver 
and Reisen 2010). 
 Yellow Fever (YFV) is an example of both the second and third factors. YFV is 
maintained by non-human primates in the forests of South America and Africa primarily by 
mosquitoes in the genuses Haemagogus and Sabethes in the Americas, and non-urban Aedes  
(Ae.) spp. in Africa (1986; Huang 1986; Cardoso Jda, de Almeida et al. 2010). YFV has been 
diagnosed in people who have been exposed to the sylvatic transmission cycle of YFV either 
through recreational (hiking) or work-related habits (nomadic herdsmen) (Gershman, Schroeder 
et al. 2009; Vasconcelos 2010; 2011). In addition, YFV sometimes escapes this sylvatic cycle 
and enters the urban cycle via Ae. aegypti, which is the bridge vector from sylvatic to urban 
Yellow Fever (Cardoso Jda, de Almeida et al. 2010; Vasconcelos 2010; 2011).  
 Vertical or transtadial transmission may play an important role in maintenance of many 
arboviruses, and specifically in tick-borne viruses (Baqar, Hayes et al. 1993; Lambrechts and 
Scott 2009; Ruzek, Yakimenko et al. 2010; Unlu, Mackay et al. 2010). However, vertical 
transmission of arboviruses, particularly WNV and DENV, has been only sporadically observed 
in natural mosquito populations (Gunther, Martinez-Munoz et al. 2007; Angel and Joshi 2008; 
Unlu, Mackay et al. 2010), and experimentally with SLE, Powassan viruses, and some 
bunyaviruses (Costero and Grayson 1996; Lambrechts and Scott 2009; Flores, Diaz et al. 2010). 
The relative importance of vertical transmission with mosquito-borne viruses, especially with 
regard to DENV and CHIKV transmission, is still considered low (Watts, Harrison et al. 1985; 
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Gunther, Martinez-Munoz et al. 2007; Hutamai, Suwonkerd et al. 2007; Vazeille, Mousson et al. 
2009). 
 Dengue virus, however, has a different transmission cycle. A true anthroponosis, DENV 
does not have an enzootic cycle, but instead is maintained solely by the urban transmission cycle 
from Ae. aegypti mosquitoes and humans (Weaver and Reisen 2010). Some genetically distinct, 
sylvatic (forest associated) DENV has been detected, and may be maintained in Africa among 
non-human primates and associated mosquito species (Rico-Hesse, Harrison et al. 1997; de 
Thoisy, Lacoste et al. 2009). However, in endemic urban areas such as South America and 
Southeast Asia, sylvatic cycles are likely a spillover from the urban cycle. Additionally, in places 
where Ae. aegypti are absent, some transmission has been attributed to a secondary vector, Ae. 
albopictus (Gratz 2004; Moutailler, Barre et al. 2009; Webster, Farrar et al. 2009; Lambrechts, 
Scott et al. 2010; Vazeille, Mousson et al. 2010). Figures 1.3A and B contrast the antrhoponotic 
cycle and zoonotic cycle of arboviruses.  
 
Arboviral Fitness 
 Since no vaccine is available for many arboviruses, understanding and controlling the 
vector populations is often the best and only recourse for disease control (Weaver and Reisen 
2010). However, vector control is problematic and if eradication is achieved, it is often transient 
(Teixeira, Costa Mda et al. 2009). Three important arboviruses have had significant changes in 
transmission due to fitness. Table 1.1 shows a summary of these changes and hypothesized 
effects on transmission. 
 When malaria was determined to be transmitted by mosquitoes, a new way of calculating 
the potential spread of the parasite in and from the vector population was formulated by Ronald 
Ross in a series of papers (Heesterbeek 2002). It wasn’t until George McDonald, also working 






Figure 1.3: Arbovirus transmission cycles. A) shows the simplified anthroponotic transmission 
cycle of dengue virus. B) depicts the transmission cycle of such viruses as West Nile, Yellow 
Fever, and chikungunya.  
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He defined this as “The number of infections distributed in a community as the direct result of 
the presence in it of a single primary non-immune case.”  Though he discusses the implications 
for other diseases, his paper was dedicated to the modeling of malaria (Macdonald 1952; Dye 
1992; Heesterbeek 2002). 
 In 1964, Garrett-Jones isolated the entomological parameters from MacDonald’s equation 
and introduced the term “vectorial capacity,” though it excludes the parameter of vector 
competence discussed below (Garrett-Jones and Grab 1964; Dye 1986; Dye 1992). Vectorial 
capacity (V), is a complex parameter included for vector-borne diseases and is a measure of the 
transmission rate from a vector population to a susceptible host population. Itself a dynamic 
measure of transmission, V is defined as “the number [of infections] that a specific mosquito 
population can distribute per case per day (Garrett-Jones 1964; Dye 1986; Dye 1992; Smith and 
McKenzie 2004; Anderson and Rico-Hesse 2006).”  The calculation of vectorial capacity is 
given by: 
 
   




    Equation (Eq.) 1.1 
where a is the man biting rate and m is the mosquito density; these parameters are measures of 
contact between the vector and vertebrate hosts (Macdonald 1957). The probability of daily 
survival p is a measure of the mortality rate of the vector (Macdonald 1957). The extrinsic 
incubation period (EIP) N is the time, in days, it takes for a pathogen to infect the mosquito and 
disseminate to the salivary glands where it can be transmitted (Macdonald 1957). The original 
formula of vectorial capacity has been modified to include a transmission capability parameter, 
vector competence b (Dye 1986; Hardy 1988; Reisen 1989; Dye C 1995; Black and CG 1996). 
Vector competence is defined as the intrinsic ability of a vector to acquire a virus, become  
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Table 1.1: Viral fitness affects transmission potential. Role of viral fitness changes in 
transmission of three important arboviruses, West Nile Virus (WNV), chikungunya virus 
(CHIKV), and dengue virus (DENV). 
Virus  Change  Affect on Fitness  Affect on Transmission  
WNV  Amino acid 
change 
(AàV)  
Faster and higher 
dissemination in vectors 
(Moudy, Meola et al. 2007) 
Faster transmission through bird 
populations  
CHIKV  Amino acid 
change 
(VàA)  
Higher dissemination in 
alternate vector (Tsetsarkin, 
Vanlandingham et al. 2007) 
Less competition for  “new” vector 
= increased disease?  






(see Ch. 3) 
2. Longer/more intense 
viremia (see Ch. 5) 
1. More transmission in 
vector population vs. “less 
fit” strains 
2. More transmission to 

















infected with the virus, support sufficient replication that dissemination to the salivary glands is 
probable, and ultimately transmit the virus (Hardy 1988).  
  Several vector traits have been studied with regard to vector competence differences, 
such as mosquito species, mosquito strain within species, and mosquito size (Boromisa, Rai et al. 
1987; Bennett, Olson et al. 2002; Vaidyanathan and Scott 2007; Alto, Reiskind et al. 2008). 
Vector competence for arboviruses particularly is impacted by extrinsic factors such as 
temperature differences during incubation, titer of virus offered during exposure, and larval 
competition (Hardy, Houk et al. 1983; Kramer, Hardy et al. 1983; Richards, Mores et al. 2007; 
Alto, Lounibos et al. 2008; Pesko, Westbrook et al. 2009). Estimates of vector competence can 
also be indicative of differences in vector susceptibility to arbovirus strains. Vector competence 
is estimated as the proportion of mosquitoes with a disseminated infection to the total number of 
exposed mosquitoes and can therefore be thought of as the dissemination rates within a vector 
population. 
  Comparisons of arbovirus strain-specific vector competence estimates have been used to 
support observed or hypothesized differences in transmission capability, and thus fitness 
(Anderson and Rico-Hesse 2006; Turell, Mores et al. 2006; Turell, Mores et al. 2006; Mores, 
Turell et al. 2007; van den Hurk, Hall-Mendelin et al. 2009). Typically, such comparisons are 
made at a single (optimal) time point during the extrinsic incubation period, and less commonly 
two or more time points might be used (Anderson and Rico-Hesse 2006; Moudy, Meola et al. 
2007; Kilpatrick, Meola et al. 2008; Moutailler, Barre et al. 2009; van den Hurk, Hall-Mendelin 
et al. 2009). Using the appropriate extrinsic incubation period (EIP) is crucial when calculating 
vectorial capacity (Kramer and Ebel 2003; Anderson and Rico-Hesse 2006). 
 Many researchers have used vector competence and vectorial capacity to study the 
relative fitness and success within and between arboviruses either in single or multiple vector 
populations (Lucio-Zavaleta, Smith et al. 2001; Armstrong and Rico-Hesse 2003; Brault, Powers 
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et al. 2004; Myles, Pierro et al. 2004; Anderson and Rico-Hesse 2006; Tsetsarkin, Higgs et al. 
2006; Gray, Caillaud et al. 2007; Kilpatrick, Meola et al. 2008; Brault 2009; Moutailler, Barre et 
al. 2009). In addition, vectorial capacity has been used to assess the effectiveness of control 
strategies either at the vector or viral levels (Busvine and Pal 1969; Rivero, Vezilier et al. 2010; 
Hancock, Sinkins et al. 2011). Vector competence has also been used as a phenotypic measure to 
explain the displacement of one viral strain relative to the other (Moudy, Meola et al. 2007; 
Tsetsarkin, Vanlandingham et al. 2007). Vector competence has also been used to assess the 
alteration of viral fitness in special circumstances. For example, to characterize the relative 
fitness between West Nile virus and St. Louis encephalitis virus in the context of superinfections, 
Pesko et al used dissemination rates (vector competence estimates) to infer that the virus that 
first infects Culex quinquifasciatus inhibits the second, but that some dissemination enhancement 
did occur in the case of mosquitoes primarily with St. Louis encephalitis and secondarily with 
West Nile virus (Pesko and Mores 2009).  
 While vectorial capacity can be used to assess viral fitness in vector populations, it is part 
of a larger measure to assess the overall transmission potential of an arbovirus in the entire 
transmission cycles from vector to vertebrate (Anderson and Rico-Hesse 2006). The basic 
reproductive number (R0), has been long established as a measure of transmission, specifically 
speaking to the potential of a pathogen to become endemic, epidemic, or disappear from the 
population. If R0<1, an outbreak is less likely to become an epidemic, and if R0>1 an epidemic 
is likely to occur (Breban, Vardavas et al. 2007). R0 speaks to the transmissibility of a pathogen 
as well as epidemic potential. With vector-borne diseases, vectorial capacity is an important 
component in R0. However, equally as important are the parameters that speak to the vertebrate 
involvement in the transmission cycle.  
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 R0 has been calculated several different ways with the definition of parameters varying. 
The traditional equation used to calculate R0 for vector-borne diseases is given below (Garrett-
Jones 1964).  
 
     R0 = cV/r      Eq. 1.2 
Recovery rate of the vertebrate (1/r)- which is sometimes written as the reciprocal (r), or days of 
infection - and infectivity to the vector (c) are vital to the transmission cycle. R0 has been used to 
judge or predict the probability and/or force of an epidemic due to pathogen introduction or 
evolution, and extrinsic factors such as climate change or seasonality (Wonham, Lewis et al. 
2006; Massad, Ma et al. 2008; Rubel, Brugger et al. 2008; Brugger and Rubel 2009; Stoddard, 
Morrison et al. 2009; Pinho, Ferreira et al. 2010). In addition, it has been used to assess the 
effectiveness of control or intervention methods, such as educational programs or vector control 
strategies (Woolhouse, Dye et al. 1997; Dumont and Chiroleu 2010). 
 Arboviruses must be ingested by the arthropod vector via a viremic blood meal from the 
infected vertebrate host, then it must escape the midgut and disseminate to the salivary glands 
where it can then be transmitted to a naïve vertebrate host. The inherent ability of these 
arthropod vectors to support this biological life stage is called vector competence, and the time it 
takes to imbibe and then transmit the pathogen is the extrinsic incubation period. These 
biological factors within the vector are critical when studying disease transmission. Specifically, 
the replicative success of a particular virus within a particular vector will greatly inform any 
modeling efforts.  
 Replicative success is also a measure of viral fitness (Clarke, Duarte et al. 1993). In an 
epidemiological context, replication implies transmission from vertebrate host via arthropod 
vector to vertebrate host; therefore, the basic reproductive number (R0) has been proposed as a 
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metric for viral fitness (Anderson and May 1992; Lipsitch and Moxon 1997; Day 2001). 
Selective pressure exists within these arbovirus systems in both the vector and vertebrate, leading 
to differential viral fitness, based on intrinsic viral characteristics (Cologna, Armstrong et al. 
2005). The effects of this selective pressure can be identified by creation of fitness indices, 
which in turn will act as mathematical weights in multi-strain/serotype systems. Accounting for 
fitness and competition among strains will greatly increase the accuracy of any model, especially 
when the co-circulation of strains and serotypes translates to disease manifestation (Halstead 
2007). Both kinetics and fitness must be accounted for in any accurate modeling system.  
 R0 has been used as a measure of the transmission potential of arboviruses (Wonham, 
Lewis et al. 2006; Foppa and Spielman 2007; Rubel, Brugger et al. 2008). R0 has also provided a 
basis of determining what characteristics affect transmission patterns of pathogens (Hartemink, 
Purse et al. 2009). Some other uses of R0 include the determination of the relative importance of 
transmission routes (vertical vs. horizontal), the effects of ecological parameters such as 
temperature, humidity and climate change, and the effects of human movement on transmission 
(Foppa 2005; Brugger and Rubel 2009; Cosner, Beier et al. 2009; Gould and Higgs 2009; Jeger, 
Madden et al. 2009; Stoddard, Morrison et al. 2009; Reiter 2010). 
 Fitness of arboviruses has been hypothesized to be constrained by the requirement of two 
main hosts: vector and vertebrate. This “trade-off” hypothesis has been studied in several 
arboviruses both in vivo and in vitro. This idea was first proposed by Taylor and Marshall in 
1975 using Ross River virus (Taylor and Marshall 1975; Taylor and Marshall 1975) and 
hypothesizes that extraordinary fitness in either the vector or the vertebrate is “traded” for 
adequate fitness in both. Since then, studies have been performed assessing the trade-off of 
fitness of arboviruses, and many of these studies have found that arboviruses that are 
increasingly adapted to a particular cell type (vector or vertebrate) become decreasingly efficient 
in that cell type or in that animal. Also, when alternating passages are used, the efficiency of a 
 14 
viral strain can be “rescued” or maintained (Cologna, Armstrong et al. 2005; Greene, Wang et al. 
2005; Ciota, Lovelace et al. 2007; Coffey, Vasilakis et al. 2008; Moutailler, Roche et al. 2011). 
Given this hypothesis, it was important that arboviral fitness and the affect on transmission be 
investigated in both the vector and vertebrate, and the potential importance of differential 
phenotypes in both hosts be accounted for. 
 
West Nile Virus 
 WNV is an important zoonotic disease infecting avian species and occasionally causing 
neuroinvasive disease in mammals, most often horses and humans (Kramer, Li et al. 2007). First 
isolated from a patient in Uganda in the 1930s, WNV was not associated with epidemics until the 
1950s (Smithburn, Hughes et al. 1940; May, Davis et al. 2011). In the 1990s, periodic epidemics 
began occurring in Europe, Israel, and North Africa, including human deaths (Reiter 2010). 
WNV is maintained primarily in a bird-mosquito transmission cycle, but occasionally an 
epizootic cycle involving humans and other vertebrates, most commonly horses, emerges 
(Wonham, Lewis et al. 2006; Kramer, Li et al. 2007; Kramer, Styer et al. 2008). The primary 
vectors of WNV belong to the genus Culex (Cx.), especially Cx. pipiens, Cx. tarsalis, and  Cx. 
quinquifasciatus  (Kramer, Li et al. 2007; Kilpatrick, Fonseca et al. 2010; Molaei, Cummings et 
al. 2010). However, other mosquito genera, including Aedes, have been shown to be competent 
for the virus and may act as bridge vectors (Moskvitina, Romanenko et al. 2008; CDC 2009; 
Larson, DeGroote et al. 2010).  
 In humans, most cases are mild or inapparent, requiring little to no medical intervention. 
As mentioned above, humans are dead end hosts and do not support viremia sufficient to infect 
mosquitoes. However, in the elderly or immunocompromised, the virus can invade the central 
nervous system and cause meningitis (WNM) or encephalitis (WNE). Most meningitis patients 
recover, though those with encephalitis have a bleaker prognosis. In an outbreak in Colorado, 
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18% of patients with WNE died and another 75% required increased care after discharge (Bode, 
Sejvar et al. 2006).   
 In equine species, a similar pattern of WNV infection is seen. Most cases are inapparent 
and the animals recover fully. However, in a small proportion of cases, neurological symptoms 
manifest and mortality can be as high as 57%. Several commercially licensed vaccines are 
available for use in horses, with indications for protection against and/or decrease in WNV 
viremia (Dauphin and Zientara 2007). In addition, some vaccines are available for use in bird 
species such as geese, in an effort to control transmission (Dauphin and Zientara 2007).  
 WNV is commonly separated into two distinct lineages, though some separate it into as 
many as five lineages. Some evidence associates lineage I more often with outbreaks of human 
and equine disease (Kramer, Li et al. 2007; Kramer, Styer et al. 2008; Weaver and Reisen 2010; 
Kauffman, Franke et al. 2011; May, Davis et al. 2011). However, others have shown that lineage 
II is just as capable of spilling over into epizootic cycles (Kutasi, Bakonyi et al. 2011; Papa, 
Bakonyi et al. 2011; Sirbu, Ceianu et al. 2011). Lineages III and IV are characterized by single 
isolates, and lineage 5 remains geographically confined to India (Kramer, Styer et al. 2008). 
 The WNV that first emerged in the United States in 1999 in New York City was of 
lineage I. This strain was most closely related to a 1998 isolate from Israel, with >99.8% identity 
(Lanciotti, Roehrig et al. 1999). This invading arbovirus caused significant morbidity and 
mortality in the resident bird population, especially in the American crow population (Corvus 
spp.), in addition to human cases of neuroinvasive disease (Lanciotti, Roehrig et al. 1999; Asnis, 
Conetta et al. 2000). There have been several studies linking clade changes or genetic diversity 
to phenotypic differences, some of which have been positively linked to epizootic transmission 
of the virus (Davis, Beasley et al. 2004; Ebel, Carricaburu et al. 2004; Bertolotti, Kitron et al. 
2008). Further, in 2001, a mutation resulted in increased fitness in Culex mosquitoes and WNV 
quickly spread across the United States (Jerzak, Bernard et al. 2005; Snapinn, Holmes et al.  
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Figure 1.4: West Nile virus maps reflect surveillance reports released by state and local 
health departments to CDC's ArboNET system for public distribution (2000). Map shows 
the distribution of human neuroinvasive disease (encephalitis and/or meningitis) incidence 
occurring during 2000 with number of human cases shaded according to incidences ranging from 
.01 to 9.99, 10 to 99.99, greater then 100, and WNV activity (human, mosquito, veterinary, avian 
and sentinel data). (CDC) 
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Figure 1.5: West Nile virus maps reflect surveillance reports released by state and local 
health departments to CDC's ArboNET system for public distribution (2002). Map shows 
the distribution of human neuroinvasive disease (encephalitis and/or meningitis) incidence 
occurring during 2002 with number of human cases shaded according to incidences ranging from 
.01 to 9.99, 10 to 99.99, greater then 100, and WNV activity (human, mosquito, veterinary, avian 
and sentinel data). (CDC) 
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2007; Kramer, Styer et al. 2008). The change in WNV activity in the United States from the year 




 Chikungunya (CHIKV) is a mosquito-borne Alphavirus (family Togaviridea) found in 
tropical areas such as Africa and Southeast Asia, as well as Italy. The virus was first isolated 
from a febrile patient in Tanzania in the early 1950s, and has since been responsible for periodic  
outbreaks of severe flu-like illnesses that can progress to severe arthralgia in some patients 
(Lumsden 1955; Robinson 1955; Mason and Haddow 1957). Because of its shared landscape 
ecology and symptoms with dengue, many CHIKV cases are likely misdiagnosed as dengue, so 
is probably more prevalent than thought (Chevillon, Briant et al. 2008; Santhosh, Dash et al. 
2009).  
 CHIKV has historically been transmitted in its urban cycle by the mosquito Ae. aegypti, 
though Ae. albopictus was considered a fairly competent vector as well (Cavrini, Gaibani et al. 
2009; Paupy, Ollomo et al. 2010). Likely the virus is maintained in a sylvatic cycle in Africa by 
non-human primates and their associated mosquitoes (Ae. africanus, Ae. furcifer-taylori, Ae. 
dalzieli, i.e.), as well as small rodents and possibly birds (Pialoux, Gauzere et al. 2007; Powers 
and Logue 2007; Thiboutot, Kannan et al. 2010). However, in Asian and India, the virus has 
persisted or re-emerged consistently in an urban, anthroponotic cycle (Figure 1.3A). This 
primarily involves the vector Ae. aegypti in Asia and in combination with Ae. albopictus in India, 
though the relative importance of interactions between these co-existing vectors has yet to be 
definitely assessed. Two distinct lineages of CHIKV have been identified: one comprised the 
West African isolates and the other of South/East African (sometimes referred to as Central/East 
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African) strains and strains isolated from Asia (Powers and Logue 2007; Kariuki Njenga, Nderitu 
et al. 2008). Interestingly, unlike WNV or DENV, very little localized genetic diversity is seen 
during an epidemic of CHIKV (Figure 1.6) (Powers and Logue 2007).  
 Beginning in 2004-2005, a significant outbreak of CHIKV began in Kenya and is 
believed to be the progenitor of the outbreaks in Comoros and La Reunion islands. Phylogenetic 
analysis of six strains from the 2004-2006 outbreaks (Comoros, Kenya, La Reunion) and several 
other earlier strains show that with high bootstrap probability, the isolates from 2004-2006 
outbreaks formed a distinct clade with the amino acid changes resulting in little phylogenetic 
distance (Kariuki Njenga, Nderitu et al. 2008). This is especially interesting given that a single of 
these amino acid changes discussed below resulted in significant fitness differences, 
underscoring the importance of phenotypic analyses for transmission studies.  
 In 2006, an outbreak on La Reunion Island was particularly significant, resulting in 
hundreds of thousands of cases of CHIKV (Gerardin, Guernier et al. 2008; Staikowsky, Talarmin 
et al. 2009). The isolate from this island was noted to have an amino acid change at at position 
226 of the envelope (E1) protein caused an amino acid substitution, changing an alanine to a 
valine (Tsetsarkin, Vanlandingham et al. 2007; Kariuki Njenga, Nderitu et al. 2008). The 
presence of this amino acid change is not particularly phylogenetically relevant, since 
phylogenetic analysis firmly places this strain in a clade consisting of 16 other amino acid 
changes (Kariuki Njenga, Nderitu et al. 2008). Figure 1.6 from Kariuki Njenga, et al shows the 
extreme conservation of isolates from the 2004-2006 outbreak. 
 However, this mutation (E226V) has been shown to enhance the efficiency of viral 
replication within the mosquito Ae. albopictus (Tsetsarkin, Vanlandingham et al. 2007; Vazeille, 
Moutailler et al. 2007). There have been several reports that Ae. aegypti was absent from the 
island, and Ae. albopictus was determined to be the primary vector of that outbreak (Vazeille, 





Figure 1.6: Phylogram of the full-length CHIKV genomic sequence demonstrating the 
extreme genetic conservation seen during the course of the outbreak. Complete nucleotide 
sequences of isolates from coastal Kenya, the Indian Ocean and India from 2004 to 2007 were 
compared using a neighbour-joining algorithm. The prototype strain (S27) was used to represent 
the historical Central/East African genotype. Bootstrap values are indicated at the nodes. 
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advantage contributed significantly to the transmission of this CHIKV strain in this otherwise 
secondary vector species, resulting in considerable transmission and human cases. Additionally, 
CHIKV strains with this amino acid change have continued to spread throughout India and 
Southeast Asia and to Europe, where Ae. aegypti coexists with Ae. albopictus, and the potential 
role of this mosquito species has not been vigorously studied (Vazeille, Jeannin et al. 2008; 
Cavrini, Gaibani et al. 2009). 
 
Dengue Virus 
 Dengue virus (DENV) is a significant international public health threat with the potential 
to become a health security issue as it continues to emerge throughout the tropics and reaches 
across national borders (2009). The virus has been responsible for episodic outbreaks since the 
first suspected epidemic in the 18th century (Rush 1789; Vasilakis and Weaver 2008). In recent 
years DENV has quickly become one of the leading causes of morbidity in tropical regions, and 
it is estimated that nearly two-fifths of the world is at risk for contracting DENV (2009).  
 The economic impact of DENV per family in highly endemic areas is often more than the 
average family’s monthly income (Suaya, Shepard et al. 2009). The mean cost per case in 
international dollars when eight endemic countries were co-analyzed was $514 per ambulatory 
patient and $1,394 per hospitalized patient (Suaya, Shepard et al. 2009). In the Americas 
specifically, the median cost of ambulatory DENV cases is $472 (USD) and hospitalized cases 
cost $1,227 (Shepard, Coudeville et al. 2011). DENV infections are now routinely detected in the 
border region of Texas, in Hawaii, and in coastal/port cities such as Boston, New York, Miami, 
and the District of Colombia, with autochthonous transmission occurring in Key West and 
Miami, Florida in 2009 (2002; 2007; Brunkard, Robles Lopez et al. 2007; 2010).  
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 The transmission of DENV is not fully explained by relative prevalence and case-
reporting data alone. There are four antigenically related serotypes (D1, D2, D3 and D4) of 
DENV that cause acute febrile illness and less commonly lead to severe manifestations of the 
disease, DENV hemorrhagic fever (DHF) or DENV shock syndrome (DSS) (Armstrong and 
Rico-Hesse 2001; Ooi and Gubler 2009). The serotypes have overlapping spatial and temporal 
distributions in densely populated, endemic areas, where the incidence of infection and cases of 
severe disease have been steadily increasing since 1978 (Thu, Lowry et al. 2004; Zhang, 
Mammen et al. 2005; Balmaseda, Hammond et al. 2006; Suwandono, Kosasih et al. 2006; 
Jarman, Holmes et al. 2008; Kukreti, Chaudhary et al. 2008; 2009; Endy, Yoon et al. 2010). 
Additionally, since the late 1970s, DENV has become a yearlong public health concern, instead 
of a disease primarily of the rainy season (Nagao and Koelle 2008).  
 The problem of dengue arises from the complexity of the pathogenesis. As a person 
recovers from a primary infection, there is a transient immunity to all four serotypes, estimated 
to last from 3 to 4 months. However, after this period, protection only to the infecting serotype 
lasts (Endy, Nisalak et al. 2004). If the same individual were to contract a secondary 
infection(Bagny, Delatte et al. 2009) from a heterologous serotype, he/she is then at increased 
risk for contracting either DHF or DSS (Guzman, Kouri et al. 1991; Endy, Nisalak et al. 2004). 
Currently, the widely accepted hypothesis is that antibody to the primary infecting serotype 
enhance the infectivity of the secondary infecting serotype. This is called antibody dependent 
enhancement (ADE), but does not explain all cases of DHF and DSS. This concept was 
introduced by Halstead and O’Rourke in 1977, who showed that D2 virus entered and replicated 
in monocytes with greater efficiency when complexed with non-neutralizing antibody compared 
to virus without antibody. This study did not, however, identify the non-neutralizing antibodies 
as heterotypic; that is, as being primarily antibodies of a different serotype (Halstead and 
O'Rourke 1977). Studies in Cuba and Thailand offered evidence that heterotypic antibodies were 
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the driving force behind increased risk for DHF and DSS (Sangkawibha, Rojanasuphot et al. 
1984; Burke, Nisalak et al. 1988; Thein, Aung et al. 1997; Rothman 2004). Further, there is 
evidence that the sequence of serotype infection (D1à D2 vs. D2 à D1, i.e.) also affects the 
severity of disease, with a secondary infection with dengue serotype 2 increasing the likelihood 
of hemorrhagic manifestations (Guzman, Kouri et al. 2002; Alvarez, Rodriguez-Roche et al. 
2006). 
 ADE has thus hindered the development of a vaccine as immunity inferred by a 
monovalent vaccine puts the population at risk for DHF or DSS. Recent vaccine efforts have 
focused on multi-valent formulations, though tetravalent vaccines have had problems with 
immunological equality. That is, a strong elicited immune response for one serotype precludes an 
effective response to another (Guy and Almond 2008; Webster, Farrar et al. 2009). Thus, efforts 
have focused on understanding and mitigating the transmission of dengue virus in endemic areas. 
 To that end, several studies have undertaken to understand the factors driving dengue 
transmission. As discussed above, external factors such as seasonality, temperature, vector 
populations, and human movement have been investigated. Intrinsic viral characteristics, such as 
genetic factors, have also been implicated in transmission differences. Outbreaks of the severe 
forms of DENV fever have been linked to changes in the dominant circulating serotype. For 
example, in Myanmar the largest outbreak in that region occurred in 2001. This outbreak was 
associated with the emergence of DENV 1 as the dominant serotype, displacing the other three. 
In that country, D1 completely displaced the other three serotypes for a definitive serotype 
switching event (Thu, Lowry et al. 2004). But also, within serotype changes have been 
implicated in changes in epidemic outbreaks or persistence. In Mexico, frequent lineage 
replacements were noted over the course of a 27 year epidemic. A total of 11 lineage changes 
were noted over this time course and little overlap among lineages was noted, though this had 
little impact on the co-circulation of the four serotypes (Carrillo-Valenzo, Danis-Lozano et al. 
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2010). Diversification of D1 in Colombia was suggested to be tied to atypical disease 
presentation (Mendez, Usme-Ciro et al. 2010). In Thailand, microevolution and the presence of 
genetic diversity in relative proximity was observed in a study involving 11 schools. The 
significant genetic variation within genotypes of D1, D2, and D3 in focused locations, such as 
the variation seen among these closely situated schools in Kamphaeng Phet, Thailand (Figure 
1.7) was positively associated with differential disease outbreaks among students (Jarman, 
Holmes et al. 2008). This variability of strains speaks to the inter- and intra-serotype 
competition, which must surely be driven, at least in part, by viral fitness advantages. 
 
Objectives and Rationale 
 The overall hypothesis of this research is as follows:  Phenotypic differences of 
arboviruses alter the transmission potential of these arboviruses by conferring fitness advantages 
in either the vector or the vertebrate. Further, these phenotypic differences need not be of large 
magnitude to affect the relative transmission potential. 
 The specific aims addressed are: 
1. To identify whether intrinsic viral characteristics can lead to differential transmission in a 
given locale. This was addressed in the first study (Chapter 2) where genetic diversity of 
West Nile virus could be associated with differential transmission of the virus. This study 
was the catalyst to the subsequent research involving phenotypic variation. 
2. To assess viral fitness in the mosquito vector and the potential for differential fitness to 
lead to significant differential transmission potential. To address this aim, we first 
addressed the issue of mosquito mortality and the interaction with vector competence of 
arboviruses. This led to a novel formulation of vectorial capacity (cumulative vectorial 
capacity) and vector competence (effective vector competence). Further, we offer the first 




Figure 1.7: Microevolution of DENV. Genetic variation within D2 Asian I genotype in schools 
from a study in Thailand. In the same study, similar levels of diversity were seen within dengue 










even small phenotypic differences can have strong implications for the relative 
transmission potential of co-circulating arboviral strains. 
3. To apply our newly formulated methods from Aim 2 to an ongoing question in the field 
of arbovirology to show that our methods could directly aid in the explanation of a still 
puzzling phenomenon. We show that our methodology can only detect significant 
differences in phenotype where traditional methods do not, applying our methods to 
already published data of chikungunya virus and the outbreak on La Reunion Island in 
2006. We show that phenotypic changes among strains of CHIKV can offer explanation 
of the expansion of one strain over the previously dominant strain where genetic typing 
has thus far failed to do so. 
4. To explore phenotypic differences in the vertebrate. Investigating the transmission 
potential of different dengue strains, we first developed a novel model for dengue 
transmission in a mouse which retains more of an immune response than other mouse 
models used in disease studies. This allows for more investigation of the immune 
responses that potentially mitigate infection establishment (transmission). In addition, we 
offer a potentially new avenue for fitness exploration in the innate immune response to 
different strains, specifically the type II interferon response. We also describe the first 
successful transmission of dengue virus from mosquitoes to mice, as well as acquisition 
from viremic mice to naïve mosquitoes. 
5. To assess how these phenotypic differences in both hosts could alter transmission 
potential. We combined the data from Aims 3 and 4 into a single measure of transmission 
potential in the form of a modified R0. While this is not a final formulation, we 
determined even small differences in effective vector competence or the length and 
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Factors Associated with Mosquito Pool Positivity and the Characterization of the West Nile 




 West Nile Virus (WNV) is the most widely distributed arbovirus in the world, occurring 
on all continents save Antarctica (Kramer, Styer et al. 2008). Its lack of vector specificity 
compared to other arboviruses has allowed it to use a wide variety of mosquito species in its 
enzootic cycles (Lanciotti, Roehrig et al. 1999). WNV was introduced into the United States in 
1999 and from its entry point of New York City it spread across the continental United States. 
Phylogenetic evidence traced this strain to a similar strain isolated in Israel in 1998 (Lanciotti, 
Roehrig et al. 1999). In 2001 a new WNV strain appeared. In 2002, this genotype became the 
dominant WN02 strain that was significantly associated with an increase in numbers of human 
morbidity and mortality cases in the US. In fact, the number of deaths from 1999-2001 were 
significantly less than the number of deaths in 2002 alone, though whether this association is due 
to direct virulence in humans or an indirect result of the virulence in birds and spread throughout 
the US remains unclear (Davis, Ebel et al. 2005; Moudy, Meola et al. 2007; Kramer, Styer et al. 
2008). 
 WNV is a member of the genus Flavivirus, a group of positive sense RNA viruses. The 
genome is composed of a single open reading frame that produces ten viral proteins: three 
structural proteins (capsid C, membrane prM/M, envelope E) and seven non-structural proteins 
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(NS1, NS2A, NS2B, NS3 NS4A, NS4B, and NS5) (Brinton 2002). The NS3 gene plays an 
important role in the replication of the virus, encoding a protein with four functions: a serine 
protease, a nucleoside triphosphatase, an RNA 5’triphosphatase, and a helicase (Brinton 2002). 
Phylogenetic analyses of WNV  have most commonly utilized differences in the envelope 
protein, but the capsid, prM protein, and non-structural proteins have also been informative 
(Ebel, Dupuis et al. 2001; Lanciotti, Ebel et al. 2002; Beasley, Davis et al. 2003; Davis, Ebel et 
al. 2005; Jerzak, Bernard et al. 2005; Davis, Galbraith et al. 2007; Bertolotti, Kitron et al. 2008; 
Gray, Veras et al. 2010). Analyses done on complete genomes have given similar results to trees 
made from prM and envelope proteins (Davis, Ebel et al. 2005). To determine the genetic 
variability in Louisiana, the envelope coding and NS3 coding regions were analyzed. The NS3 
gene has a high level of substitution and is phylogenetically informative (Gray, Veras et al. 2010) 
and mutations in the envelope region has been postulated to enable viruses subvert immune 
responses (Pfeffer, Foster et al. 2006). Analysis of these genes would illustrate the variation 
present in Louisiana as well as provide improved insight for our phylogenetic model. 
 Many phylogenetic studies have been geographically focused (Ebel, Dupuis et al. 2001; 
Andreadis, Anderson et al. 2004; Ebel, Carricaburu et al. 2004; Bertolotti, Kitron et al. 2008). 
Geographic Information Systems (GIS) based “region” classifications were successfully used to 
model WNV transmission risk in humans in northeast Ohio where local environmental features 
to model transmission (LaBeaud, Gorman et al. 2008). Employing a similar eco-regionalization 
method, we hypothesized that WNV pool positivity was correlated with regional environmental 
characteristics. Further, we postulated that the phylogenetic delineations would be associated 







Materials and Methods 
Samples 
According to the mosquito surveillance data, there are two primary species of mosquitoes 
that serve as possible WNV vectors to people in Louisiana: Culex quinquefasciatus and Aedes 
albopictus. There were twenty six species from eight genera captured and submitted for testing. 
Of these, fifteen species were found to be positive for WNV (Table 2.1).  
 
Mosquito Trap Sites and Field Collection of Mosquitoes 
 Data was provided by Louisiana parish mosquito control departments. Each parish 
operates independently with its own trapping protocols and methods. Not all parishes actively 
sampled throughout the year due to considerations of the local mosquito activity levels. We 
therefore analyzed the months that all target parishes had in common (June-November), which 
captured the majority of the WNV transmission period (Richards, Mores et al. 2007). 
 Mosquitoes were sexed and the females were pooled according to genus and species; that 
is, one pool consisted of a single species. The pools were then homogenized and submitted to the 
Louisiana Animal Disease Diagnostic Laboratory (LADDL) at the Louisiana State University 
(LSU) School of Veterinary Medicine (SVM). LADDL is the state testing facility for mosquito 
pools for all parishes, so criteria for positive pools is the same across all parishes.  
 
Virus Detection and Sequencing 
 Pools were obtained from the LADDL at the LSU SVM. Viral RNA was extracted from 
140 µl of the supernatant from the mosquito pool homogenate using the QIAmp Viral RNA 
Extraction Kit following manufacturer’s instructions (Qiagen, Valencia, CA). One microliter of 
the extracted viral RNA suspension was used as template for the reverse-trascriptase polymerase 




Table 2.1: Species in positive mosquito pools: Mosquito pools by species positive for WNV in 
2007 from the four target parishes. 
Species in Positive Mosquito Pools 
Genus Species Number of positive pools 
Aedes albopictus 12 
 triserriatus 1 
 vexans 5 
Anopheles quadrimaculatus 1 
Culex coronator 2 
 erraticus 3 
 nigrapalpus 1 
 quinquefasciatus 129 
 restuans 1 
 salinarus 1 
 tarsalis 1 
Mansonia titillans 2 
Psorophora columbiae 3 
 Ferox 2 








previously described protocol (Chisenhall, Vitek et al. 2008). Upon confirmation of the presence 
of amplified viral DNA by gel electrophoresis, the remaining sample was cleaned using Qiagen 
PCR Cleanup kit following manufacturer’s instructions. Cleaned DNA was then sent to the Gene 
Probes and Expression Systems Laboratories of the Division of Biotechnology and Molecular 
Medicine at the Louisiana State University School of Veterinary Medicine for sequencing. 
Sequencing was performed on a Beckman Coulter 8800 (Pasadena, CA) using the manufacturer’s 
reagents and methods. 
 
Statistical Analysis 
 SAS version 9.1.3 was used to code the data as a binary response, where a mosquito pool 
that was positive for was coded as ‘1’ while the negative pools were coded as ‘0.’  The 
probabilities reported are the probabilities of the event=1 (WNV positive). A confidence level of 
95% was used for all tests; a stepwise selection process was invoked to cull out non-significant 
effects from the model.  
PROC GLIMMIX with a binary distribution specified was used to construct the model 
and obtain the odds ratios, as well as to obtain differences in least squares means for the effects 
of parish and month. PROC GLIMMIX is a useful alternative to PROC LOGISTIC when 
wanting to obtain differences in least squares and/or modeling random effects, which is not easily 
done in PROC LOGISTIC. Predicted means and odds ratios are the same between the two 
procedures. Confidence intervals and tests for significance will vary when random effects are 
included the model in PROC GLIMMIX, but there were no random effects modelled here 








 The complete envelope (E) and non-structural protein 3 (NS3) genes were aligned 
separately for all successfully recovered isolates as well as 24 reference strains, which 
represented the Israel 1998 strain and isolates spanning the contiguous United States and one 
Mexican isolate (Ebel, Carricaburu et al. 2004). Alignments and the creation of the E-NS3 
contigs were done using Vector NTI software and exported to GeneDoc for trimming. 
Alignments were imported into MEGA 4 and converted to MEGA format. Bootstrap analysis 
(n=1000) using maximum parsimony was performed and a tree produced. As the topologies of 
the E and NS3 phylogenies were the same, our tree represents a contiguous sequence of these 
two genes. The topology tree was collapsed with a node confidence of 70%. Genetic distances 
and means were also obtained using Mega 4 (Tamura, Dudley et al. 2007). Not all samples in the 
statistical model were available for the phylogenetic analysis. 
 
Results  
Positive Pool Predictors 
 The data used in the modelling study were from several parishes in Louisiana during 
2007. There were 611 positives reported by the Louisiana Animal Disease Diagnostic 
Laboratory, 165 in our target parishes. Classification regions were constructed based on land 
cover data from the Louisiana GIS Digital Map, May 2007 (Figure 2.1). The land cover of a 
parish was determined by the majority rule. Ouachita and Caddo parishes are, for example, 50-
75% forest lands; East Baton Rouge is a majority developed area comprised mostly of the 
urbanized capital of Baton Rouge (Harper 2006). Iberville Parish is classified as wetlands, 
defined as low-lying areas saturated with moisture. 
	   Before building the WNV model, we tested several factors via multinomial regression to 




WNV positivity. Interestingly, no factors (land cover, month) were significant for the 2007 data. 
Therefore, it was determined that no noteworthy correlation existed between these variables and 
thus no colinearity issues would arise by inclusion of all variables in the model. 
 The model originally included the effects of month, mosquito genus and species; but 
through a stepwise selection procedure, the variable species was not significant at the alpha=0.05 
level and thus eliminated from the model. This is likely due to the overwhelming number of 
Culex quinquefasciatus, which comprised over 61% of the total pools (Ntotal=3246) and 88% of 
the positive pools (Table 2.1). This is consistent with earlier studies where Cx. quinquefasciatus 
was found to be the most abundant and likely epizootic vector for the virus (Gleiser, Mackay et 
al. 2007; Mackay, Roy et al. 2008). In addition, all interactions were not significant and therefore 
removed from the model. 
 Locations of isolates were coded according to land cover. The model included land cover, 
genus, and month. Type of regional land cover was a significant effect (p < 0.0001) indicating 
that there is an ecological component driving WNV activity. Additionally, month was significant  
(p < 0.0001); and thus there is a temporal component that contributes to the probability of getting 
a positive mosquito pool. This trend can be seen in figure 2.2.  
 The pair wise differences in least squares means are given in table 2.2 with Tukey 
adjusted p-values showing where the significant differences lay. Forested lands are clearly more 
likely to have a positive mosquito pool as compared to developed areas and wetlands. Similarly, 
August appears to be the month where a positive mosquito pool is more likely. August and July 
are eight and six times more likely to see a positive mosquito pool than June, respectively. 
Interestingly, August and July are not significantly different from the months of September-
November. All months are significantly different from June, which is the least likely month 






Figure 2.1: Louisiana landcover. Louisiana GIS Digital Map, May 2007shows the land cover of 





over seven times more likely in July than June. The overall trends of land cover and month are 




 The phylogenetic tree resulting from the contiguous segment comprised of the envelope 
and NS3 sequences is shown in figure 2.3. All samples are, unsurprisingly, of the 2002 lineage. 
However, there appears to be some diversity within both forested and wetland areas. Particularly, 
there is a possible small sub-group with samples 4893, 8441, and 3077. The samples from the 
wetlands show the possibility of a distinctive group; in particular, sample numbers 3766 and 
3767. There is a clear delineation between forest and wetland samples based on two nucleotide 
substitutions in the NS3 gene: an adenine to guanine at positions 5760, and a cytosine to uracil at 
position 6324., Samples were grouped as follows: Israel 1998 as the root; the wetlands as a 
group; a small grouping of forest samples; a NY99 group; and the remaining were grouped 
together as representative of the North American 2002 clade. The between and within distances 
were computed according to the Jukes-Cantor model (table 2.3). Genetic diversity within 
Louisiana was modest when compared to isolates from a wide geographic range. The genetic 
distances within the eco-regions (forest vs. wetlands) in Louisiana were greater than the distances 
comparing Louisiana and those strains from outside of Louisiana. Table 2.4 identifies sample 




 In some locations, WNV positivity in mosquito pools serves as a predictor for human 
cases (Andreadis, Anderson et al. 2004). Our findings that the month of collection and eco-region 
were significant predictors of positive pools suggest that ecological and temporal factors 






Figure 2.2: Positive pool probability over months by land cover. Predicted probability of a 




Table 2.2:	  Differences of least square means: The differences in the least square means 
reported as odds ratios with Tukey adjusted p-values show significant differences between types 
of land cover and month. 
	  






Developed Forest 0.279 <.0001 
Wetland Forest 1.346 0.0076 
July June 6.65 0.0006 
August June 8.98 <.0001 
September June 7.09 0.0001 





























Figure 2.3: Maximum parsimony phylogenetic tree. Phylogenetic tree based on 1000 
bootstraps of the maximum parsimony analysis of the WNV E and NS3 contiguous sequence. 
Branches indicating Louisiana isolates are coded by eco-region with isolate ID in parentheses. 
Other sequences included in this phylogeny include the following GenBank accession numbers: 
AF260967, DQ164201, DQ164195, DQ164191, DQ164190, DQ164189, DQ164203, 
DQ164204, DQ164199, AY712948, DQ164194, DQ164192, AY033389, DQ164196, 
DQ164197, DQ164193, DQ164205, AY963775, DQ164200, DQ164198, DQ164202, 







WNV infection. Mosquito abatement programs are operated on a parish-wide basis, so any useful 
model would ideally work for the parish as a whole. Therefore, looking at the ecology of the 
parish as a whole- and even grouping parishes into ecological regions or types- will assist in 
determining a robust model as we did in our pool positivity model, can be used at the very least, 
on a parish level. Ideally, a model would serve the state as a whole, focusing on regional activity. 
 Phylogenetic analysis will also help us better understand how the changes in the genome 
may lead to a change in virulence. It is interesting that the statistical model predicts positive 
pools in forested areas while the phylogenetic study shows more diversity in the wetland areas. It 
is also interesting that there is more genetic diversity within Louisiana than without. That is, the 
diversity when comparing between the wetlands and forests within Louisiana is greater than the 
diversity when comparing the Louisiana isolates and those outside of the state. This suggests that 
WNV evolution is not as constrained in Louisiana as compared to other locations as has been 
suggested in other  (Chisenhall and Mores 2009). Further, some component of eco-regions could 
have an important role in diversification. This could be due to a difference in bird populations 
found in each of these ecologies, or it could be a function of extrinsic, microhabitat conditions, 
such as temperature or humidity which could exert a selection pressure on the viruses. 
 The phylogenetic analysis shows that there has been no reversion in Louisiana from the 
2002 lineage which replaced the originally introduced strain. Our statistical model serves as a 
basis for future testing, directing mosquito control efforts and surveillance programs. Though we 
believe our findings to be a significant start to a potentially long term project, it was not without 
its pitfalls. For example, there is a confounding factor of spatial clustering of the ecologies tested. 
However, if the spatial component was the only source of diversity, thus discounting the 
ecological diversity, we would not expect that the phylogenetic signature of the Southern 
Louisiana strains should be markedly different in topology than the Northern Louisiana strains. 




Table 2.3: Genetic distances for 2007 samples: Genetic distances of the 2007 samples from 
Mega 4.0 show more variability within Louisiana than when Louisiana is compared to the rest of 
North American isolates. 
 
Genetic Distances for 2007 Samples 
 Within  Between 
Louisiana .29104  .4751 Outside LA .56137  






Table 2.4: Origin and classification of sequenced isolates: The isolates that were successfully 
sequenced are listed by land cover classification. The parish where each was collected is 
identified and accession numbers for E (envelope) and N (NS3) sequences are given as well. 
	  
Land Cover ID Number Parish Accession Number (E/N) 
Wetlands 3766 St. Bernard HM538823/HM538811 
 3767 St. Bernard HM538824/HM538812 
 3219 St. Bernard HM538829/HM538807 
 4242 Iberville HM538825/HM538810 
 1487 Jefferson HM538827/HM538806 
 4687 Jefferson HM538826/HM538808 
 1906 Jefferson HM538828/HM538809 
Forrest 3055 Caddo HM538821/HM538813 
 1085 Caddo HM538817/HM538805 
 4860 Ouachita HM538822/HM538816 
 4893 Ouachita HM538818/HM538803 
 8441 Ouachita HM538819/HM538804 







strains, which were characterized by a lack of phylogenetic structure, suggests the diversity seen 
within these regions is the result of some other, perhaps ecological, characteristic.  
 Additionally, the specificity of the land cover classification needs to be more precise. 
This land cover generalization to parish is a good start to determine if further investigation is 
garnered, and here we show that it is. Understanding how land cover and regional ecology effects 
mosquito pool positivity will help focus mosquito abatement efforts. This would especially help 
in areas where abatement programs are limited due to either funding or man power. Moreover, 
understanding how regional environments drive phylogenetic variation will lead to a greater 




Andreadis, T. G., J. F. Anderson, et al. (2004). "Epidemiology of West Nile virus in Connecticut: 
a five-year analysis of mosquito data 1999-2003." Vector Borne Zoonotic Dis 4(4): 360-
378. 
 
Beasley, D. W., C. T. Davis, et al. (2003). "Limited evolution of West Nile virus has occurred 
during its southwesterly spread in the United States." Virology 309(2): 190-195. 
 
Bertolotti, L., U. D. Kitron, et al. (2008). "Fine-scale genetic variation and evolution of West 
Nile Virus in a transmission "hot spot" in suburban Chicago, USA." Virology 374(2): 
381-389. 
 
Brinton, M. A. (2002). "The molecular biology of West Nile Virus: a new invader of the western 
hemisphere." Annu Rev Microbiol 56: 371-402. 
 
Chisenhall, D. M. and C. N. Mores (2009). "Diversification of West Nile virus in a subtropical 
region." Virol J 6: 106. 
 
Chisenhall, D. M., C. J. Vitek, et al. (2008). "A method to increase efficiency in testing pooled 
field-collected mosquitoes." J Am Mosq Control Assoc 24(2): 311-314. 
 
Christofferson, R. C. (2008). Old vs. New: A comparison of PROC LOGISTIC and PROC 
GLIMMIX. SAS Global Forum, San Antonio, TX. 
 
Davis, C. T., G. D. Ebel, et al. (2005). "Phylogenetic analysis of North American West Nile virus 





Davis, C. T., S. E. Galbraith, et al. (2007). "A combination of naturally occurring mutations in 
North American West Nile virus nonstructural protein genes and in the 3' untranslated 
region alters virus phenotype." J Virol 81(11): 6111-6116. 
 
Ebel, G. D., J. Carricaburu, et al. (2004). "Genetic and phenotypic variation of West Nile virus in 
New York, 2000-2003." Am J Trop Med Hyg 71(4): 493-500. 
 
Ebel, G. D., A. P. Dupuis, 2nd, et al. (2001). "Partial genetic characterization of West Nile virus 
strains, New York State, 2000." Emerg Infect Dis 7(4): 650-653. 
 
Gleiser, R. M., A. J. Mackay, et al. (2007). "West Nile virus surveillance in East Baton Rouge 
Parish, Louisiana." J Am Mosq Control Assoc 23(1): 29-36. 
 
Gray, R. R., N. M. Veras, et al. (2010). "Evolutionary characterization of the West Nile Virus 
complete genome." Mol Phylogenet Evol. 
 
Harper, R. A. (2006). Forest Inventory & Analysis Factsheet Louisiana 2005. USDA. 
 
Jerzak, G., K. A. Bernard, et al. (2005). "Genetic variation in West Nile virus from naturally 
infected mosquitoes and birds suggests quasispecies structure and strong purifying 
selection." J Gen Virol 86(Pt 8): 2175-2183. 
 
Kramer, L. D., L. M. Styer, et al. (2008). "A global perspective on the epidemiology of West 
Nile virus." Annu Rev Entomol 53: 61-81. 
 
LaBeaud, A. D., A. M. Gorman, et al. (2008). "Rapid GIS-based profiling of West Nile virus 
transmission: defining environmental factors associated with an urban-suburban outbreak 
in Northeast Ohio, USA." Geospat Health 2(2): 215-225. 
 
Lanciotti, R. S., G. D. Ebel, et al. (2002). "Complete genome sequences and phylogenetic 
analysis of West Nile virus strains isolated from the United States, Europe, and the 
Middle East." Virology 298(1): 96-105. 
 
Lanciotti, R. S., J. T. Roehrig, et al. (1999). "Origin of the West Nile virus responsible for an 
outbreak of encephalitis in the northeastern United States." Science 286(5448): 2333-
2337. 
 
Mackay, A. J., A. Roy, et al. (2008). "West Nile virus detection in mosquitoes in East Baton 
Rouge Parish, Louisiana, from November 2002 to October 2004." J Am Mosq Control 
Assoc 24(1): 28-35. 
 
Moudy, R. M., M. A. Meola, et al. (2007). "A newly emergent genotype of West Nile virus is 
transmitted earlier and more efficiently by Culex mosquitoes." Am J Trop Med Hyg 
77(2): 365-370. 
 
Pfeffer, M., J. E. Foster, et al. (2006). "Phylogenetic analysis of Buggy Creek virus: evidence for 
multiple clades in the Western Great Plains, United States of America." Appl Environ 




Richards, S. L., C. N. Mores, et al. (2007). "Impact of extrinsic incubation temperature and virus 
exposure on vector competence of Culex pipiens quinquefasciatus Say (Diptera: 
Culicidae) for West Nile virus." Vector Borne Zoonotic Dis 7(4): 629-636. 
 
Tamura, K., J. Dudley, et al. (2007). "MEGA4: Molecular Evolutionary Genetics Analysis 













 The transmission potential of a vector borne disease has been used to predict risks of 
outbreaks, evaluate vector control strategies, and to compare strains of a pathogen (Garrett-Jones and 
Shidrawi 1969; Kramer and Ebel 2003; Anderson and Rico-Hesse 2006). An accurate measure of 
this potential is critical, and often estimated by vectorial capacity (VC) (Smith and McKenzie 2004). 
Vectorial capacity was originally devised by MacDonald in 1957 for malariologists, and represents 
“the number [of infections] that a specific mosquito population can distribute per case per day 
(Macdonald 1957; Garrett-Jones 1964; Dye 1992; Smith and McKenzie 2004).”  The calculation of 
vectorial capacity is given by: 
 
    !" = !!
!!!!
! !"!
     Equation (Eq.) 3.1 
 
where a is the man biting rate and m is the mosquito density; these parameters are measures of 
contact between the vector and vertebrate hosts (Macdonald 1957). The probability of daily survival 
p is a measure of the mortality rate of the vector (Macdonald 1957).  The extrinsic incubation period 
(EIP) N is the time, in days, it takes for a pathogen to infect the mosquito and disseminate to the 
salivary glands where it can be transmitted (Macdonald 1957).  The original formula of vectorial 
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capacity has been modified to include a transmission capability parameter, vector competence b 
(Dye 1986; Hardy 1988; Reisen 1989; Dye C 1995; Black and CG 1996).  These last two 
parameters, EIP and b, capture intrinsic viral characteristics and have been used to evaluate 
differences in pathogen strains (Armstrong and Rico-Hesse 2001; Armstrong and Rico-Hesse 2003; 
Moudy, Meola et al. 2007; Tsetsarkin, Vanlandingham et al. 2007). Other researchers have 
recognized the importance of understanding the parameters in vectorial capacity as well as 
characterizing the interaction of important parameters, EIP, survival rate and vector competence, as a 
means for evaluating infection risks (Kramer and Ebel 2003; Cohuet, Harris et al. 2010). 
  Vector competence b is the ability of an arthropod to transmit an infectious agent following 
exposure to that agent (Hardy 1988). Several vector traits have been studied with regard to vector 
competence differences, such as mosquito species, mosquito strain within species and mosquito size 
(Boromisa, Rai et al. 1987; Bennett, Olson et al. 2002; Vaidyanathan and Scott 2007; Alto, Reiskind 
et al. 2008). Vector competence for arboviruses particularly is impacted by extrinsic factors such as 
temperature differences during incubation, titer of virus offered during exposure, and larval 
competition (Hardy, Houk et al. 1983; Kramer, Hardy et al. 1983; Richards, Mores et al. 2007; Alto, 
Lounibos et al. 2008; Pesko, Westbrook et al. 2009). Estimates of vector competence can also be 
indicative of differences in vector susceptibility to arbovirus strains. Indeed, several studies have 
shown that vector competence of dengue virus varies within a single serotype (Armstrong and Rico-
Hesse 2001; Armstrong and Rico-Hesse 2003). Vector competence is estimated as the proportion of 
mosquitoes with a disseminated infection to the total number of exposed mosquitoes and can 
therefore be thought of as the dissemination rates within a vector population. 
  Comparisons of arbovirus strain-specific vector competence estimates have been used to 
support observed or hypothesized differences in transmission capability (Anderson and Rico-Hesse 




Hall-Mendelin et al. 2009). Typically, such comparisons are made at a single (optimal) time point 
during the extrinsic incubation period, and less commonly two or more time points might be used 
(Anderson and Rico-Hesse 2006; Moudy, Meola et al. 2007; Kilpatrick, Meola et al. 2008; 
Moutailler, Barre et al. 2009; van den Hurk, Hall-Mendelin et al. 2009). Using the appropriate 
extrinsic incubation period (EIP) is crucial when calculating vectorial capacity (Kramer and Ebel 
2003; Anderson and Rico-Hesse 2006). However, the continuous interaction between EIP and vector 
competence has not been evaluated in terms of vectorial capacity estimates.  Further, the importance 
of the mosquito survival rate is also critical given as it sets time constraints on the EIP. The 
importance of the interaction of mosquito lifespan, EIP and vector competence is recognized, but 
there has, until now, not existed a method to evaluate this interaction with more than rudimentary 
comparisons (Ghosh, Moreira et al. 2002; Kramer and Ebel 2003; Smith and McKenzie 2004; 
Anderson and Rico-Hesse 2006; Walker and Lynch 2007; Cohuet, Harris et al. 2010). 
 Instead of evaluating vectorial capacity and vector competence at discrete time points, as 
traditional use of vector competence data allows, vector competence can be modeled as a function of 
the rate of change over time in days, giving a value we term “effective vector competence (EVC).” 
This value is bounded by the survivability of the mosquito population, given that it includes pN as a 
crucial evaluative parameter.  This EVC can then be put back into the vectorial capacity equation as 
a parameter, resulting in a vectorial capacity curve as a function of time.  Utilizing the EVC and 
vectorial capacity curve rather than single day or even day-by-day vector competence values 
accounts for the importance of the mosquito lifespan. When taken in concert, EIP (now a range of 
days), vector competence, and daily survival rate captures a more accurate picture of the natural 
transmission potential of a pathogen.  Accordingly, we investigated the rate of change in vector 
competence, over a given interval, of dengue virus in Aedes aegypti mosquitoes, and the resulting 




curves represents the average vector competence bounded by mosquito lifespan and the average 
cumulative transmission potential of the arboviruses within a population of mosquitoes for a given 
time interval, respectively.  Four strains of dengue virus were evaluated in this manner to 
demonstrate the value of this model based on our experimental data.  Further we use previously 
published data on both West Nile virus and chikungunya virus to prove the validity our model.  
 The use of vectorial capacity to statistically compare virus transmission differences has been 
limited due to the inability to efficiently test differences, and often the statistical comparisons are 
limited to the vector competence data (Rattanarithikul, Konishi et al. 1996; Reifenberg, Cuisance et 
al. 1997; Sithiprasasna, Linthicum et al. 2003; Anderson and Rico-Hesse 2006).  Because vector 
competence is a parameter of proportion, each estimate of vectorial capacity contains within it an 
entire experiment aimed at estimating vector competence. Statistical methods that are readily 
available to researchers would require several replications of vectorial capacity estimates or artificial 
computer simulations.  We used the calculated area under the curve for each virus strain in this study 
and calculated a corresponding variance estimate based on the inherent variance in the vector 
competence functions.  We then used these estimates to test for differences in cumulative 
transmission potentials between strains of dengue virus based on our dynamic model.  
 The purpose of this modeling effort is to demonstrate that day-by-day comparisons of vector 
competence alone are not sufficient to offer consistent estimates of viral fitness.  Additionally, the 
inclusion of the daily survival rate of the mosquito population makes the vector competence function 
much more relevant, as these bounds on EIP are important for fitness evaluation. Implicit in our 
calculation of a cumulative measure is the assertion that transmissibility at earlier time points is 
critical to characterizing epidemiologically relevant differences in viral strains, and that those 
differences are less apparent or lost when vectorial capacity is calculated with single day measures 




day value of EIP in the field is impossible to pinpoint and unlikely to be meaningful (outside of point 
source introduction of virus), a range of time covering the transmission critical period will more 
accurately represent what is happening under natural conditions.  In order to more accurately 
evaluate viral fitness, we offer a model of cumulative vectorial capacity and effective vector 
competence to show that 1) single day comparisons are inadequate and 2) even with the collection of 
day-by-day vector competence values, a cumulative evaluation is needed. 
 
Materials and Methods 
Mosquitoes  
 Aedes aegypti (Linnaeus) Rockefeller strain mosquitoes from the colony at Louisiana State 
University School of Veterinary Medicine were used in this experiment. Cartons containing 
approximately 100 individuals were kept in an environmental chamber at 28°C, 75-80% humidity, 
and subjected to a 16:8 light:dark regime.  Mosquitoes were provided water after emergence until the 
time of blood-feeding; no mortality due to sugar starvation was observed. After blood-feeding, 




 Four strains of dengue from Southeast Asia were utilized in this experiment to demonstrate 
the hypothesized behavior of a multiple strain system. Three strains of serotype 2 (16803, 1232 and 
16681) and one strain of serotype 4 (LN 634441) were propagated by inoculating a T-75 flask of 
confluent Vero cells with 100 µl of viral stock for 15 minutes (Alto, Lounibos et al. 2008). Ten mL 
of M199E medium with 10% newborn calf serum and 2% penicillin/ streptomycin/ fungizone was 




at peak levels. Viral standard curves and concentrations were obtained via plaque assay as described 
previously before the beginning of the experiment and titers were verified throughout the 
experiment, including testing of blood meal titers, by qRT-PCR as previously described (Chisenhall 
and Mores 2009). We used the SuperScript III One-step qRT-PCR kit (Invitrogen, Carlsbad, CA) as 
per manufacturer’s instructions.  
 
Oral Exposure of Mosquitoes and Detection of Disseminated Infection 
 Mosquitoes were offered an infectious blood meal 3-5 days post emergence with an 
infectious titer of 106 pfu/ml for all strains. The blood meal consisted of bovine blood in Alsevier’s 
anticoagulant (Hemostat, Dixon, CA) mixed 2:1 with a virus solution in a total volume of 
approximately 3 ml per carton, heated to 37°C and kept warm via the Hemotek device (Discovery 
Workshops, Arrington, Lanceshire, UK). Mosquitoes were allowed to feed for 45 minutes before the 
blood meal was removed. Mosquitoes were then sorted and only fully engorged females were kept; 
all others were discarded.  Engorged females were identified by the presence of red blood in the 
abdomen, visible with the naked eye and these mosquitoes were our exposed cohort.  Mosquitoes 
were then sampled at days 5, 7, and 9 post exposure to test for dissemination status. Sample sizes at 
each day are given in table 3.1. 
A disseminated infection where virus is present in legs and tissues other than the midgut, has 
been used to assess vector competence of dengue in Aedes mosquitoes, as well as other arboviruses 
in mosquito vectors. (Turell, Gargan et al. 1984; Armstrong and Rico-Hesse 2001; Moncayo, 
Fernandez et al. 2004; Alto, Reiskind et al. 2008). Mosquito legs were removed and analyzed 
separately for infection from the bodies. Legs and bodies were put into separate vials containing 900 
µl of BA-1 diluent (Lanciotti, Kerst et al. 2000) and then homogenized at 20 Hz for 2 minutes using 




nucleic acid extraction instrument according to the manufacturer’s instructions (Thermo Scientific). 
After extraction, the samples were tested for the presence of dengue viral RNA via qRT-PCR using 
the following protocol: RT step (1 cycle) 48˚C for 2 minutes, 95˚C for 2 minutes; amplification and 
data recording step (40 cycles) 95˚C 15 seconds, 60˚C 30 seconds.  Primers were designed and 
obtained via Integrated DNA Technologies (Table 3.2) with 5’ FAM fluorophore and 3’ Black-Hole 
quencher for DEN-2 and 5’ TAMRA fluorophore and 3’ Iowa-Black quencher for DEN-4. These 
primers and probes do not cross react, and are specific to only the intended serotype of dengue. 
Vector competence was calculated as the number of disseminated infections divided by the total 
number of mosquitoes exposed, as described above. All analyses and modeling was performed in 
SAS 9.13 (Cary, NC).  The SAS Code is given in Appendices 3 and 4 for the one and two-phase 
scenarios, respectively. 
 
Effective Vector Competence (EVC) and Cumulative Vectorial Capacity (cVC) Model 
 Because we are interested in comparing viral characteristics only, we will hold m, as well as 
a (man biting rate) and p (probability of daily survival), constant. The values used in this effort are 
shown in table 3.3. The assumptions of our model are a naïve end-host population and no significant 
vertical transmission of the pathogen within the vector.  While vertical transmission has been 
observed with dengue in Aedes ageypti, levels are very low and an impact on transmission has not 
been definitively proven (Gunther, Martinez-Munoz et al. 2007; Arunachalam, Tewari et al. 2008). 
Vector competence values used in this dengue vectorial capacity modeling effort are given in table 
3.3.   
 Figure 3.1 shows traditional, single time point values of vectorial capacity calculated as in 









Table 3.2: Primer and probe sequences for dengue serotypes 2 and 4.  All sequences are 5’ à 
3’. 
















Table 3.3: Parameters of the vectorial capacity equation held constant. Parameter values of 
Aedes aegypti obtained from literature and held constant when calculating the Vectorial Capacity 





   Dissemination Rates (n) 
Serotype Strain Origin 5 dpe 7dpe 9dpe 
2 1232 Indonesia, human 0 (19) 0.35 (17) 0.44 (18) 
2 16803 Thailand, human 0 (18) 0.06 (15) 0.58 (12) 
2 16681 Thailand, human 0.045 (22) 0.28 (25) 0.35 (31) 
4 LN 634441 Malaysia, human 0 (11) 0 (11) 0.18 (11) 
Parameter Value Reference 
Mosquito Density (m) 1.9 (Jeffery, Thi Yen et al. 2009) 
Man Biting Rate (a) 3.125 (Yasuno and Tonn 1970) 




This figure highlights the importance of accounting for variation of vector competence over the 
course of time, as the rank of fitness as judged by vectorial capacity swaps from day to day. 
 
Results 
We devised a method that uses the rate of change in vector competence as part of the 
vectorial capacity equation. For each set of dissemination rates over a given interval meant to 
represent the EIP, a relationship defining b as a function of this interval was devised:   
 
    b!(N)   =   β1!N  +   β0!     Eq. 3.2 
 
where bi(N) is the function for strain i; β1 is the determined change in b per unit change in N (slope 
of the line); N is day post exposure, and β0 is the y-intercept. This line represents the rate of change 
in dissemination rates over time and the variance inherent to this line will be used to construct 
variance estimates. The interval over which this line is constructed has a lower limit of time a and an 
upper limit of z. Using the rate of change function for each strain i, EVC is defined as: 
 
    EVC =   φ = p! β!"N+   β!" dN
!
!     Eq. 3.3 
 
And cVC is now defined as:  





 As vector competence is a proportion, it is asymptotic at 0 and at 1 and the function of 






Figure 3.1: Single versus cumulative VC values: Vectorial capacity values for four strains of 
dengue at 5, 7, and 9 days post exposure (dpe) as well as the cumulative vectorial capacity (cVC) 
values. The relative fitness of the strains swaps places throughout all time points, highlighting the 
difficulty of choosing a single EIP value.  The cVC values take into account all days (5, 7, 9) and the 





characterized by a plateau before (minimum =0) and after (maximum=M) a phase of exponential 
growth within the interval [a,t] where a is the beginning of the exponential growth phase and t is the 
end of the exponential phase (Figure 3.2).  The interval (t,z] is the M-phase.   At both the 0- and M-
plateau phase of this curve, the rate of change of vector competence is either negligible or zero.  
During the 0-plateau phase, there is no mathematical contribution to the calculation of cVC, but 
during the M-plateau, the changes in cVC will largely be driven not by vector competence, but by 
the survival rate of the vector.  If the interval of experimentation does not include the M-plateau 
phase, then vectorial capacity is calculated as above, using the linear function bi(N). If the M-phase 
is sufficient enough to contribute, then cVC is calculated by adding the areas under the curve of the 
exponential and M-phases (see Appendix 5 for more details). 
 As the dengue strains used in this study did not reach M-phase over the experimental time 
interval (days 5-9 post exposure), the cVC was calculated from the exponential phase only, as in 
Supplemental Definition 1 (Appendix 5). Corresponding variance estimates are calculated using the 
variation inherent in the linear function, bi(N), from the exponential growth phase of vector 
competence.  One of the benefits of using linear regression equations to define cVC rather than 
directly incorporating the logistic function is the calculation of an accurate variance estimate, 
whereas logistic regression functions are based on maximum likelihood and thus variances often do 
not converge on true values of variance and confidence levels are approximations.  Variance 
calculations are given in Appendix 5.  The use of areas under the curve and corresponding variance 
estimates to test for differences has been established (Dill, Martin et al. 1978), but use in vector-
borne disease transmission comparisons has not been explored. The results of this method, including 






Figure 3.2 Vector competence dynamics:  The complete lack of dissemination during the 0-phase 
will contribute 0 to the cumulative vectorial capacity calculation, while the functions in both the 
exponential growth and M- phases will be incorporated into the calculation of cVC. During the 
exponential growth phase, the linear function of vector competence growth will be incorporated in 
the cVC function, while in the M-phase, where dissemination rates have reached a plateau, only the 





Statistical Test of Differences 
 We also provide a method for statistically testing the cVC.  It is important to note that cVC 
itself is not a mean or a sum, but a fine scale sum of means.  To demonstrate, we show here a simple 
sum, though in actuality we integrate over the interval to capture the continuous rates of change of 
vector competence. Let E(VCx) be the mean vectorial capacity at day X, then it follows that  
 
 
E(VC5  +   VC7  +   VC9)     =   E(VC5)+   E(VC7)   +   E(VC9)  Eq. 3.5 
 
The importance of considering the cumulative transmission potential of a mosquito population is 
depicted in Figure 3.1 where the strain of DENV with the highest dissemination rate at N=9 (D2 
16803) has the third highest cVC. 
 To test for differences between strains, confidence intervals about the mean differences in 
cVC estimates should be constructed based on an acceptable confidence level and the appropriate 
degrees of freedom (based on the sample size of the vector competence function). If the data are 
sufficiently normal, using critical values from the Student’s t-distribution is acceptable. However, a 
robust alternative if data are not sufficiently normal is the construction of confidence intervals based 
on a t-like distribution of the differences. Area estimates and variances are obtained as above after 
bootstrap re-sampling with replacement for 1000 bootstrap iterations. The differences between these 
simulated area estimates and variances per strain are then used to develop a t-like distribution which 
given the number of bootstraps, is normally distributed. A t-like distribution has the properties of the 
Student’s t-distribution, but the mean is shifted from 0 to a value dependent on the comparisons 
made.  The distribution of the differences is constructed and the values of the 2.5 and 97.5 
percentiles of this t-like distribution (t.025 and t.975, respectively) are obtained and used to construct a 




 Table 3.4: Results from the cumulative formulation of vector competence and vectorial 
capacity method for 4 strains of dengue. Effective vector competence (φ) and cumulative vectorial 
capacity (cVC) estimates obtained from our model of integration and the associated variance 
estimates for each strain.*Indicates the 95% lower and upper confidence limits for the difference 



























1232 n/a 31.7616 6.66 n/a .294 
16803 -24.3807 24.2305 5.92 12.4718 .225 
16681 -21.7204 27.6219 5.54 12.8051 .256 




obtained experimentally and the t-like distribution from the bootstrap efforts, the upper and lower 
confidence limits are obtained by: 
 
 [ 21*|025.|)21( VarVartcVCcVC +−− , 21*|975.|)21( VarVartcVCcVC +−− ]     Eq. 3.6 
 
The values cVC1, cVC2, Var1, and Var2 are the values obtained from the original computations of 
cVC based on the experimental data and bi(N); the bootstrapping is to facilitate the t-like distribution 
and  produce the values of t.025 and t.975 only. As in all interval tests of hypotheses, if the null value 
(i.e. a difference of 0) is contained within this interval, no significant difference exists between the 
compared strains. Results of pair wise testing for the cVC values of four strains of dengue are given 
in table 3.4. 
 By calculating the rate of change of vector competence and pairing this with the other 
parameters of the vectorial capacity equation, especially the survival function, a more accurate 
understanding of the comprehensive differences in the potential for transmission of arboviruses is 
obtained. For the sake of brevity, we present only the tested differences in strains with respect to an 
arbitrarily designated reference strain, D2 1232. We constructed 95% confidence intervals using 
cVC estimates and standard error estimates to test for significant differences between the reference 
strain and the other four strains. Only strain LN 634441 was significantly different from the 
reference strain (table 3.4). This demonstrates the ability of our model to distinguish between 
significant and non-significant differences. Using the definition of vectorial capacity and assuming a 
system of perfect transmission where every disseminated infection results in a successful 
transmission event, for every 10 cases of DENV transmitted from this population of mosquitoes that 




Characterization of Fitness in the Vector 
 To further characterize differences between dengue strains in the context of viral fitness, we 
devised a displacement index (DI). Viral fitness is a measure of the relative replicative abilities of a 
viral strain to a reference strain (Clarke, Duarte et al. 1993).  Vector competence can be used as a 
measure of relative fitness, and thus so can vectorial capacity and cVC (Anderson and Rico-Hesse 
2006). To isolate viral characteristics, and using the properties of integration, the “entomological” 
parameters can be moved to the outside of the integral (see Appendix 5).  
 This displacement index is then defined as: 
  
  
    







    
Eq. 3.7 
 
 When two strains (i and a reference strain REF) are co-circulating in a single population of 
mosquitoes, which is assumed to be homogeneous, the parameters considered to be intrinsic to the 
vector effectively cancel out. The DI is thus interpreted as a measure of the capability of a newly 
introduced strain to displace the established, dominant circulating strain: 
 
                                                                 !" =    !!
!!"#
      Eq. 3.8 
When the entomological parameters cancel out, the viral differences, measured as effective 
vector competence, are what determine whether one strain is capable of displacing the dominant 
circulating strain or serotype: the capability and speed of dissemination.  Our model of EVC and 
cVC captures these parameters in a more thorough measurement, and as the DI utilizes cVC and/or 
EVC, it is likewise a more complete measure of viral fitness with regards to transmission. If 




DI > 1, there exists some intrinsic characteristic of that viral strain that will infer on the displacing 
strain a competitive advantage. In this way, the DI can be used to compare intrinsic viral fitness of 
viral strains within a vector population or can be used to determine the potential of a new virus to 
invade and hijack a vector population where an established arbovirus has sustained transmission.  
 
 Discussion 
 Expectation has been that arbovirus strains with lower vector competence at late EIPs will be 
at a competitive disadvantage and an arbovirus strain with the highest ultimate value of b should out-
compete strains with lower dissemination rates at some fixed EIP. For example, the strain of West 
Nile virus originally introduced to North America (NY99) has since been displaced by another strain 
(WN02) which has a shorter extrinsic incubation period within its primary vectors, the Culex spp. 
mosquitoes (Moudy, Meola et al. 2007). Alone, the values of vector competence and EIPs are 
informative, however we detected highly variable times to initial and maximum dissemination and 
dissemination rates based on the strain of dengue virus.  Taken at each time point, strain differences 
can be seen, but no clear pattern emerges for definitive conclusions. For example, if we were to 
compare the fastest start of dissemination, D2 16681 is the only strain with any dissemination at day 
5.  At day 7, however, this strain is out disseminated by D2 1232 which then falls behind D2 16803 
at day 9 post exposure.  The highest ultimate dissemination is seen in D2 16803 (58% at 9 dpe).  
These differences across time points show the difficulty in assessing fitness at discrete points.  
Further, though D2 16803 ultimately achieves the highest dissemination rate, because of the force of 
the survival function on vectorial capacity, this strain does not possess the highest cVC and therefore 
is not necessarily the most efficiently transmitted strain.  In fact, D2 16803 did not have cVC above 




D4 LN 634441 lagged at all time points and was the only strain to be accurately assessed at each 
single time point, though this is attributable to the overall inefficiency of the strain. 
 While we use testing of legs to extrapolate transmission rates, we recognize that there has 
been no definitive evidence that proves this measure does not overestimate vector competence.  
There is no evidence to support the supposition that this overestimation would be differential across 
strains.  The lack of an accessible transmission model for dengue has confounded such 
investigations, and this further highlights the importance of moving towards such a model. 
 As vector competence is a dynamic function of time, selection of an appropriate EIP (or 
range thereof) for testing is critical (Cohuet, Harris et al. 2010). However, it is also important to note 
that at later time points, survivorship of the mosquito cohort declines. The effect of the interaction of 
vector competence and declining survivorship has on estimates of vectorial capacity had not been 
rigorously explored.  A strain that results in a smaller proportion of disseminated infections, but that 
invades much faster will infiltrate the mosquito population and perhaps render a portion of the 
vertebrate population immunologically unavailable to the strains with slower kinetics, as well as take 
advantage of a higher proportion of surviving vectors, a relationship not accurately reflected by 
simple vector competence comparisons.  This demonstrates that there is a trade-off in vector 
competence and EIP, which this model accurately captures.  This model should retain its accuracy 
and usefulness when comparing across vector populations and/or species by varying the other 
parameters according to the vector(s) of interest. 
 The argument that vectorial capacity values are most informative when used in a comparative 
way is not new (Dye 1992). A decisive, interpretable method for doing such a comparisons has until 
now, been unavailable. With this data, we demonstrate how the varying values of vector competence 
can be used to calculate the true magnitude of transmission potential and that these cumulative 




 In complex vector-borne disease transmission systems such as dengue, where multiple 
serotypes of an arbovirus co-circulate, understanding the relative kinetics of transmission of co-
circulating strains and serotypes is a vital part of understanding the overall transmission. This is 
especially so in dengue endemic areas where serotype switching events have been linked to more 
severe disease outbreaks (Thu, Lowry et al. 2004). With the understanding that entomological 
parameters cancel out in our calculation of the DI, we formulated a comparison of relative fitness.  
In a theoretical system where D2 1232 is established as the dominant strain, and the other four 
dengue virus strains have been introduced and now co-circulate, none of the strains are capable of 
overtaking the system and displacing strain 1232. Conversely, if LN was the reference and 1232 the 
invader, 1232 would have the potential to displace LN with a ratio of infectious bites of 10:4.  
Excess secondary vertebrate cases of strain 1232 translate into enhanced transmission potential to 
naïve vectors, continuing the transmission cycle with more force than the other strains and thus 
perpetuating its dominance (Figure 3.3).  
 To further validate our model, we used data from Moudy et al. that investigated the 
differences in vector competence between the NY99 and WN02 strains of West Nile virus (Moudy, 
Meola et al. 2007). The displacement index of WN02 in relation to NY99 is 2.14, a value that is 
supported by the invasion of WN02 into the West Nile transmission system and its complete 
displacement of the established NY99 strain. A pathogen such as WNV which has multiple vector 
species, can add a new level of complexity to the model. In such cases, the entomological parameters 
would have a great impact on the transmission system. But like the cVC model in general, the DI can 
be used to make comparisons made across different populations or species of vectors.  
 Similarly, we demonstrate the use of the displacement index using data from two strains of 
chikungunya virus isolated from La Reunion Island during the 2005-2006 epidemic (Tsetsarkin, 






Figure 3.3: Characterizing relative fitness: The displacement index of three dengue strains (D4 
LN 63441, D2 16681, D2 16803) compared to the reference strain (D2 1232) shows that no 








increased the efficiency of the virus within the vector Aedes albopictus (Tsetsarkin, Vanlandingham 
et al. 2007). The displacement index of the viral strains (E226V:E226A) in Ae. albopictus was 
calculated to be 1.91, and further demonstrates the use of the displacement index as a measure of 
both viral fitness within a vector and a means of comparing transmission potential.  
 As these data indicate, our cVC methodology gives a more accurate measure of the 
magnitude of transmission potential, owing to the fact that it collapses several informative 
parameters into a single, standardized measure.  In addition, it allows for direct statistical tests of 
differences in cumulative vectorial capacity where there has previously been none.  The DI provides 
a scaled index by which viral fitness can be measured and compared, an assessment which further 
characterized the four dengue strains used.  In addition, as the historical events highlight, the DI 
could indicate the potential emergence of new pathogen threats to public health, economy, and 
national security. The validation using West Nile and chikungunya data gives us confidence that this 
method will be a useful epidemiologic measure and future directions include investigations of field 
isolated dengue from endemic areas.   
 In summary, the cVC model along with the DI provides a conceptual and methodological 
basis by which virus fitness differences can be evaluated within an epidemiologically satisfying 
framework.  This methodology will be additionally useful in retrospective characterizations of 
observed viral genetic and phenotypic differences detected during past epidemics, where attribution 
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 Chikungunya virus (CHIKV) is a mosquito-borne Alphavirus found in tropical areas such as 
Southeast Asia, India, and parts of Africa.  This virus has been responsible for periodic outbreaks of 
severe flu-like illnesses and can lead to lifelong arthralgia in some patients (Powers and Logue 
2007).  CHIKV has historically been associated with transmission by the mosquito Aedes (Ae.) 
aegypti, though Ae. albopictus is a fairly competent vector as well (Moutailler, Barre et al. 2009; 
Pesko, Westbrook et al. 2009; Talbalaghi, Moutailler et al. 2010; van den Hurk, Hall-Mendelin et al. 
2010).  An outbreak in Kenya began in 2004 that is believed to be the progenitor of the outbreaks on 
the Comoros and La Reunion islands.  Phylogenetic analysis of six strains from the 2004-2006 
outbreaks (Comoros, Kenya, La Reunion) and several other earlier strains show that with high 
bootstrap probability, the isolates from 2004-2006 outbreaks formed a distinct clade with the amino 
acid changes resulting in little phylogenetic distance (Kariuki Njenga, Nderitu et al. 2008).   
Despite this relative genetic stability, an increase in transmission was noted especially in 
2006 when an outbreak on La Reunion Island resulted in over 100,000 cases of CHIKV (Gerardin, 
Guernier et al. 2008; Staikowsky, Talarmin et al. 2009).  Since there had been several reports that 
the primary vector, Ae. Aegypti, was absent from the La Reunion Island, and Ae. albopictus was 
determined to be the primary vector of the outbreak there (Bagny, Delatte et al. 2009).  Further 
investigation into the role of this alternate vector during this outbreak revealed an amino acid 
substitution at position 226 of the envelope (E1) protein, changing an alanine to a valine.  This 




species Ae. albopictus (Vazeille, Moutailler et al. 2007; Delatte, Dehecq et al. 2008; Delatte, Paupy 
et al. 2008).  The substitution was not associated with an increased fitness in vertebrate cell lines or 
baby mice, further attributing the epidemic to fitness in the vector (Bordi, Meschi et al. 2011; 
Tsetsarkin, Chen et al. 2011).   
 Curiously, this substitution reportedly did not cause a synonymous fitness advantage in Ae. 
aegypti and perhaps was even deleterious in the mosquito at days 7 post exposure (Tsetsarkin, 
Vanlandingham et al. 2007).  This would suggest that the substitution resulted in an advantage only 
in Ae. albopictus and thus, the increase in transmission on La Reunion Island was due in large part to 
the absence of Ae. aegypti (Vazeille, Moutailler et al. 2007; Delatte, Dehecq et al. 2008; Delatte, 
Paupy et al. 2008).  However, the E226V strain continued to spread throughout Africa, into Sri 
Lanka, the Indian subcontinent, and Southeast Asia over several years where such an absence of Ae. 
aegypti does not occur (Schuffenecker, Iteman et al. 2006; de Lamballerie, Leroy et al. 2008; 
Hapuarachchi, Bandara et al. 2010).  
 Even more intriguing is the recent study that showed that endemic strains, even with the 
AlaninàValine substitution introduced, did not confer the same fitness advantage in native Thailand 
Ae. albopictus colonies as seen in the outbreak (E226V) vs. pre-outbreak (E226A) strains in 
experimental colonies (Tsetsarkin, Chen et al. 2011).  The authors of this study also suggest that 
evolutionary forces have favored fitness advances in Ae. aegypti in Southeast Asia where Ae. 
albopictus has coexisted for at least 60 years.  They also suggest that the AàV mutation 
accumulation takes over 15 transmission cycles, which would indicate that the fitness advantage in 
Ae. albopictus is not necessary for sustained transmission (Tsetsarkin, Chen et al. 2011).  Therefore, 
the role of Ae. aegypti is not only still relevant, but vital to understanding the expansion of this 




Given the magnitude of the displacement by the post-substitution genotype (E226V), there 
must be at least some fitness advantage of that genotype in Ae. aegypti mosquitoes compared to the 
previously endemic Southeast Asian CHIKV.  The first step in determining whether CHIKV 
transmission can be solely attributed to Ae. albopictus in this region is to investigate the vector 
competence of the La Reunion 2006 outbreak strain (LR06) relative to the previously endemic 
Southeast Asian strains.   
 Most comparisons of arboviral fitness are done with vector competence measures.  However, 
this measure alone is not sufficient to facilitate fine scale and field relevant comparisons.  For 
example, a virus strain that achieves no dissemination in the mosquito vector population at a certain 
day post exposure will be determined to be less fit than a strain that has at least some dissemination 
at that time point.  Days later, however, the first strain may have achieved higher dissemination than 
the second, and the resulting conclusions are completely opposite.  Further, if dissemination rates are 
ultimately higher for one strain, but the time it takes to reach that proportion is so long that most of 
the mosquito population cannot survive, then the fitness advantage is not as apparent as it would 
seem.  Thus, the effective vector competence (EVC) measure is a more accurate assessment of viral 
fitness.  Furthermore, the use of the displacement index (DI) shows the directionality of any fitness 
advantage (Christofferson and Mores 2011). 
We hypothesized that some significant phenotypic differences must exist between CHIKV 
strains with the E226V substitution and those without the substitution in order for the E226V 
genotype to have penetrated Southeast Asia where Ae. aegypti is still reportedly the primary vector.  
To test this, we reanalyzed the previously published data regarding the dissemination rates of the 
outbreak and pre-outbreak strains from La Reunion Island in Ae. aegypti mosquitoes, using our 




(Tsetsarkin, Vanlandingham et al. 2007). Further, we experimentally compared the outbreak strain 
with a Southeast Asian (SVO 476-96) strain of CHIKV assumed to be more like the endemic strains 
found in that region. The goal was to determine whether the E226V genotype had a fitness 
advantage over viral types more similar to those formerly endemic to Southeast Asian that would 
facilitate the displacement in the region independent of its perceived fitness differences from the La 
Reunion Island-specific pre-outbreak conditions.   
 
Materials and Methods 
Virus 
 For our experimental infections of chikungunya, two strains were utilized.  Viruses were the 
generous gift of Dr. Robert Tesh, University of Texas Medical Branch, Galveston and Dr. Ann 
Powers, CDC, Fort Collin, CO, respectively.  The La Reunion 2006 strain used in the experimental 
study herein is an unadapted strain isolated originally from a patient on La Reunion Island in 2006 
(LR06).  The Southeast Asian strain is a human isolate from Northeast Thailand (Phayao) in 1996 
(SEA96). Each strain was propagated in Vero cells, through a single passage. Viral standard curves 
and concentrations were obtained via plaque assay as described previously (Christofferson and 
Mores 2011).  Titers were verified throughout the experiment by qRT-PCR using standard Taqman 
conditions with the SuperScript III One-step qRT-PCR kit as per manufacturer’s instructions 
(Invitrogen).  Primer and probe sequences for each strain are given in table 4.1 (Reiskind, Pesko et 
al. 2008).  Strains utilized in Tsetsarkin, et al. are full length, infectious clones with GFP tags 
(Tsetsarkin, Vanlandingham et al. 2007).  The outbreak strain (E226V) contains the substitution 
strain with the alanineàvaline substitution and the pre-substitution strain (E226A) was isolated from 






 Ae. aegypti (Linnaeus) Rockefeller strain mosquitoes from the colony at Louisiana State 
University School of Veterinary Medicine were exposed to an artificial bloodmeal 3-5 days post 
emergence with approximately 106 pfu/.1 ml of either a SEA96 or LR06. Mosquitoes were kept at 
constant environmental conditions: 16:8 light:dark cycle, 28°C and 75-80% humidity. 
 
Mosquito Exposure and Detection of Disseminated Infection 
Feeding occurred as previously described (Christofferson and Mores 2011).  Fully engorged 
females were placed into clean, one-quart cartons and then sampled at days 3, 5, and 7 days post 
exposure (dpe) to test for dissemination status. Approximately 15-17 mosquitoes per time point per 
strain were sampled.  It has been previously shown that detectable arbovirus in the legs is indicative 
of a fully disseminated infection; thus the salivary glands are presumed to be infected as well 
(Turell, Gargan et al. 1984). Mosquito legs were removed and analyzed separately for infection from 
the bodies as previously described (Alto, Lounibos et al. 2008; Reiskind, Pesko et al. 2008; Turell, 
Dohm et al. 2008; Pesko, Westbrook et al. 2009; Christofferson and Mores 2011). RNA was 
extracted using the MagMax-96 kit (Ambion) on a King Fisher® nucleic acid extraction instrument 
according to the manufacturer’s instructions (Thermo Scientific). After extraction, the samples were 
tested for the presence of chikungunya viral RNA via qRT-PCR using the following protocol on the 
Roche LightCycler480: RT step (1 cycle) 48˚C for 2 minutes, 95˚C for 5 minutes; amplification and 
data recording step (40 cycles) 95˚C 15 seconds, 60˚C 30 seconds.  
 
Data Analysis 
  Vector competence was calculated as the number of disseminated infections divided by the 




calculated as in (Christofferson and Mores 2011). All analyses and modeling was performed in SAS 
9.13 (Cary, NC).  EVC values are determined as part of the cumulative vectorial capacity (cVC) 
measurement.  It is a cumulative measure of vector competence over a range of days, bounded and 
weighted by the mosquito lifespan.  Briefly, define the rate of change of vector competence over 
days as bi(N): 
bi(N)= β0	  +	  β1N	   	   	   	   Equation (Eq.) 4.1	  
 
where β1= rate of change of vector competence over time.  EVC, represented by the Greek letter phi 
(φ) is then given by: 
φ=	  ∫	  pNbi(N)	  dN	   	   	   	   	   Eq. 4.2 
where N is the extrinsic incubation period, here a range of days defined by the research; bi(N) is as 
above; and p= probability of daily survival.  This is held constant so as to isolate the viral 
phenotypes and assess relative fitness (Christofferson and Mores 2011).  The EVC value can be 
plugged into the cVC equation but EVC gives a measure of viral fitness while entomological and 
vertebrate density parameters are held constant and thus not included in EVC.   
 To determine fitness advantages between E226V and E226A, La Reunion data from 
Testsarkin, et al. was used and EVC obtained (Tsetsarkin, Vanlandingham et al. 2007).  The same 
calculations were used for our experimental data. 
 
Results 
Reanalysis of Tsetsarkin, et al. E226V Strain vs. E226A in Ae. aegypti.   
 Dissemination rates of the two strains, E226V and E226A, were similar at each time point 




the first few time points. Dissemination rates, calculated EVC values, and the 95% lower and upper 
confidence limits for the test of difference are given in table 4.2 (Tsetsarkin, Vanlandingham et al. 
2007).  Though traditional day-by-day comparisons did not detect any statistical significance in the 
fitness of E226V in Ae. aegypti mosquitoes, the EVC estimate did.  The difference of the two EVC 
calculations was significant at the p=.05 level.   Using a t-test of the bootstrapped values, a 
significant difference between the two strains within Ae. aegypti mosquitoes was detected at the 
p<.05 level.  Surprisingly, the results show that the substitution in E226V actually conferred a slight 
but statistically significant disadvantage in Ae. aegypti. Compared using the displacement index 
(DI), a measure of relative fitness. The E226A strain was 1.17 times as fit as the E226V strain when 
calculated based on the original Tsetsarkin 2007 data. 
 
Experimental Comparison of LR06 and SE96 
 Dissemination rates and EVC for the SEA96 and LR06 strains are given in table 4.3. The 
LR06 strain had not only an earlier start of dissemination but ultimately reached three times the 
dissemination in Ae. aegypti compared to SEA96.  Thus, the EVC calculation and bootstrapped test 
showed that LR06 had a statistically significant advantage in Ae.aegypti (p<.05).  The overall 
advantage is again best reported as relative fitness.  The DI value reported here is calculated as the 
ratio of fitness SEA96:LR06 and is .4.  The reciprocal of this gives the level of fitness of LR06 
compared to SEA96.  Thus, LR06 is 2.5 times more fit than SEA96 in Ae. aegypti. 
 
Discussion  
 Here we show that the La Reunion strains, E226V and E226A, differ significantly as judged 
by EVC in Ae. aegypti, while previous studies showed no significant difference. We concluded that 




pre-outbreak La Reunion strain (E226A), based on reanalysis of those data (Tsetsarkin, 
Vanlandingham et al. 2007). The magnitude of this difference is further illustrated by the 
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With a DI of 1.17 indicating that the E226A strain is 1.17 times more fit than E226V, it would be 
expected that E226V would not displace the E226A strain in areas where Ae. aegypti would likely be 
the primary vector. (Figure 4.1)  However, this has not been the case as this mutant has become the 
predominant strain detected (Schuffenecker, Iteman et al. 2006; de Lamballerie, Leroy et al. 2008; 
Hapuarachchi, Bandara et al. 2010).  Since this mutation nonetheless expanded into Southeast Asia 
where Ae. aegypti is still predominant, we hypothesized that some advantage must exist in Ae. 
aegypti outside of the focus of La Reunion Island. Thus, we investigated the relative fitness of the 
LR06 strain with a Southeast Asian strain of CHIKV that did not have the AlaàVal mutation.  We 
found that the SEA96 strain without the substitution did have a substantial fitness disadvantage 
compared to the LR06 strain, with a DI of .4.  Thus, there is a sufficient phenotypic advantage of this 
mutation in Ae. aegypti compared to the endemic, resident strain to allow for displacement of that 
endemic strain. Since the E226A/E226V data is a reanalysis and the SEA96 comparison is from our 
experimental efforts, direct comparisons of these two values should be made carefully as laboratory 
conditions and methods of virus detection varied. More investigation of the phenotypic relationship 
of this SEA96 strain to the pre-outbreak La Reunion strain is needed to fully correlate these results 
to the spread of the newly emerged strain across India and Southeast Asia.  The expectation is that 





Table 4.1: Primers and probe.  The sequences for the primers and probe used to amplify CHIKV 




Table 4.2: Dissemination rates.  Dissemination rates from Tsetsarkin, et al. and the calculated EVC 
rates with the 95% confidence limits for the test of difference between LR06 and Pre-LR strains. 
Strain P 




e in EVC 
UCL of 
difference 
in EVC 1 dpe 3 dpe 5 dpe 7 dpe 9 dpe 12 dpe 
E226A .91 0 0.15742 0.58279 0.89679 0.94816 1 
2.92 
-0.8364 -0.2729 
E226V 0 0.39352 0.68547 0.74121 0.95084 0.945 2.49 
Southeast Asian strain vs. E226V in orally exposed Ae. aegypti.  
 
 
Table 4.3: Dissemination rates of experimentally exposed mosquitoes.  Dissemination rates of LR06 strain 
and the Southeast Asian strain in Ae. aegypti mosquitoes.  The calculated EVC values and the 95% 









EVC 3 dpe 5 dpe 7 dpe 






Forward Primer Reverse Primer Probe 
ACC CGG TAA GAG CGA 
TGA ACT 
ACG CCG CAT CCG 
GTA TGT 






Figure 4.1: Displacement index characterizing relative fitness.  The reference point is set a 1 as 
La Reunion 2006 compared to itself.  The E226A:E226V point represents the relative EVC values of 
the pre-La Reunion strain to the mutant La Reunion strain.  SEA96:LR06 shows the DI resulting 
from the experimental derivation of EVC of the Southeast Asian 1996 strain to the La Reunion 2006  
















































 We show that EVC values can be used to more accurately assess fitness as it can detect 
significant differences in fitness, likely due to the interaction with mosquito mortality rates. It is 
important to understand that EVC comparisons should be made in a single vector species with the 
assumption that either the viral strains compared, occur in the same population of vectors (i.e. 
holding daily survival constant is field relevant) or that differences in the probability of daily 
survival across vector populations are negligible.   
 Specifically, we report that the EVC more accurately captures fitness advantages conferred 
by the alanine to valine substitution at position 226 on the CHIKV E1 protein.  We also use the DI to 
explore the relationship among phenotypes of CHIKV strains.  Not only does the DI accurately 
direct the fitness advantage of one strain over the other, but it suggests that the phenotypic and 
phylogenetic relationships between the pre-substitution La Reunion strain (E226A) and the 
Southeast Asian strain are not sufficiently characterized to explain the spread of this mutation across 
the region, given the gap between the two in fitness.  Both the EVC estimates and DI point towards 
the need for further investigation of the E226V strain in Ae. aegypti populations, as well as the need 
for further evaluation of the mixing of two equally as permissive vectors, Ae. aegypti and Ae. 
albopictus. This illustrates that the relative in vivo, within-vector phenotype can aide in further 
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 Dengue virus (DENV) is one of the most common arboviral infections, especially in tropical 
areas affecting millions of people annually (2009). There is presently no vaccine available for 
DENV, and control of the virus via mosquito abatement has not been successful in permanently 
eradicating the virus (Teixeira, Costa Mda et al. 2009). Understanding the transmission and factors 
that could potentially mitigate transmission of this virus are vital to controlling and understanding 
outbreaks. Modeling of DENV infections and transmission in vivo has been complicated by the 
difficulty of the virus to successfully establish infections in immunecompetent mice. Recently there 
have been successful studies involving several knockout mice, particularly the AG129 model, 
deficient in both type I and type II interferon receptors. These models have most often been used to 
model dengue disease and pathogenesis, especially the severe manifestations (Shresta, Kyle et al. 
2004; Shresta, Kyle et al. 2004; Kyle, Beatty et al. 2007; Kyle, Balsitis et al. 2008; Yauch and 
Shresta 2008; Mota and Rico-Hesse 2009; Balsitis, Williams et al. 2010; Cassetti, Durbin et al. 
2010). Problems with these currently utilized mouse models include: 1) viremia levels are too 
transient or do not reach levels that adequately represent DENV infections in humans, 2) unnaturally 
high viral titers or lab adapted virus strains are necessary to establish infection and/or 3) routes of 
exposure do not resemble natural routes (i.e. intravenous or intracranial inoculations) (Johnson and 
Roehrig 1999; Chen, Lai et al. 2004; Shresta, Sharar et al. 2006; Chen, Hofman et al. 2007; Schul, 
Liu et al. 2007; Williams, Zompi et al. 2009).  
 In vitro studies have shown that dengue virus inhibits type I interferon production, indicating 
that this measure of immune response subversion is critical for dengue fitness and thus affects 
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transmission (Rodriguez-Madoz, Bernal-Rubio et al. 2010). Further, others have shown that 
downstream protein expression induced by type I interferon and the JAK/STAT pathway play 
important roles in dengue inhibition (Liu, Woda et al. 2009; Jiang, Weidner et al. 2010; Munoz-
Jordan 2010). Much attention has been given to the JAK/STAT pathway, and it has been suggested 
that dengue subversion of the type I interferon response occurs only after this pathway has been 
initiated (Mazzon, Jones et al. 2009; Munoz-Jordan 2010). The NS5 and NS3 genes of the dengue 
virus has been shown to act as regulators of the JAK/STAT subversion, but these proteins have no 
direct affect on the type II interferon response (Mazzon, Jones et al. 2009).  
 In vivo studies have also shown the importance of the type I interferon and JAK/STAT 
pathways. Importantly, studies have established the crucial role of type I interferon in early clearance 
of dengue, though none have sought to explore infection establishment (Shresta, Sharar et al. 2005). 
Studies in the AG129 mouse and many important discoveries have been facilitated by the use of this 
mouse. However, with the additional deficiency in IFN-gamma, it is impossible to discern if the two 
interferon responses act in concert to inhibit infection establishment or if one or the other is 
responsible for establishment inhibition, though some have indicated both types I and II interferon 
are necessary for disease progression (Johnson and Roehrig 1999; Shresta, Kyle et al. 2004; Shresta, 
Sharar et al. 2005; Shresta, Sharar et al. 2006).  
 When a virus infiltrates a cell via endocytosis, the RIG-1 pathway is stimulated by the 
presence of single stranded RNA, and MDA5 and endosomal TLR3 recognize double stranded 
RNA. These pathways signal through the interferon regulatory factors (IRF) 3 and 7, which sets off a 
cascade of signals resulting in the transcription of type I interferon (IFN-α/β). Figure 5.1 
demonstrates the importance of IRF3 and IRF7 in the type I interferon pathway. Briefly, through the 
activation of these pathways, NFκB, IRF-3, and low-level, constitutively produced IRF-7 localize to 




Figure 5.1: Type I interferon production signals through IRF 3 and IRF7.  Single stranded RNA 
is recognized by RIG1 in the cytoplasm and double stranded RNA is recognized cytomplasmically 
by MDA5 and in the endosome by TLR3.  The resulting signal cascades all utilize the interferon 
regulatory factors (IRF) 3 and 7 to first promote transcription of IFN-β, which positively feeds back 
via STAT1/STAT2/IRF9 to promote transcription of IRF7, which promotes transcription of IFN-α.  
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which leads to the localization of the STAT1/STAT2/IRF9 complex to the nucleus where IRF7 
transcription is promoted. Upregulated production of IRF7 leads to increased localization of IRF7 
dimers to the nucleus where the production of IFN-	  α is promoted. IFN α	  and	  β are responsible for 
the establishment and maintenance of the anti-viral state in the immune response (Katze, He et al. 
2002; Haller, Kochs et al. 2006).  
 We hypothesized that type I interferon only, and not type II, was critical for the inhibition of 
dengue virus infection establishment (transmission). We tested this hypothesis using an IRF3/7 
double knockout (DKO) strain of C57BL/6 mice. Given that mosquito saliva has been shown to alter 
infection kinetics in arbovirus infections, we further evaluated this hypothesis via a natural 
transmission route to determine whether the relative importance of types I and II interferon is 
changed by exposure route (Limesand, Higgs et al. 2003; Schneider and Higgs 2008; Thangamani, 
Higgs et al. 2010; Styer, Lim et al. 2011). 
 
Materials and Methods 
Mice  
 Mice were the generous gift of Drs. T. Taniguchi and M. Diamond. IRF 3/7 -/- -/- double 
knockout (DKO) mice are deficient in interferon regulatory factors 3 and 7, and thus have a 
significantly abbrogated type I interferon. The type II interferon and all other immune responses are 
intact though blunted (Daffis, Suthar et al. 2009). Intact C57BL/6 mice were obtained from the 
Louisiana State University School of Veterinary Medicine Division of Laboratory Animal Medicine 
and were used as controls. All experiments met the approval and conditions of the LSU Institutional 





 Three strains of dengue virus were used: two strains of dengue 2 (strain 1232 isolated from a 
patient in Indonesia, strain 16803 isolated from a patient in Thailand) and one strain of D4 (strain 
LN 634441 isolated from a patient in Malaysia). Virus was propagated as in (Alto, Lounibos et al. 
2008) before inoculation into mice. Before the experiment, virus was titered via plaque assay and 
experimental titers were confirmed at 106 pfu/ml by qRT-PCR as in (Christofferson and Mores 
2011). Since all titers were matched, no dilution was performed. 
 
Virus Inoculation and Serum Collection   
 Mice were anesthetized with isoflurane and then injected subcutaneously with 100 µl of 
supernatant from the virus inoculated cell culture. The total inoculum into each mouse was 105 
pfu/mouse. Intact C57/Bl6 controls were inoculated with 105 pfu/mouse D2 16803 in the same 
manner as the other mice. Each treatment group consisted of 4-6 mice. Mice were then bled each day 
for five days via submandibular bleeding technique (Golde, Gollobin et al. 2005). Blood was 
allowed to clot for thirty minutes on bench top, and then centrifuged at 6 rcf for five minutes. 
Clarified serum was collected and placed into a clean tube for analysis. Though there were days 
when some mice did not bleed enough for a sample analysis, no less than three mice were analyzed 
on a given day. 
  
Virus Detection 
 Viral RNA was extracted using the MagMax 95 kit (Ambion) or QIamp Viral RNA kit 
(Quiagen). Where necessary, serum samples were brought to volume with BA1 buffer and kits were 
run as per manufacturer’s instructions. Detection of viral RNA was done using a One Step Taqman 
qRT-PCR assay (SuperScript III). Primers and probes are specific to a single serotype of dengue and 
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we have observed no cross reactivity among them (Christofferson and Mores 2011). In addition, all 
assays have been tested for their sensitivity and each has detected less than 1 pfu/ml. 
 
Mosquito Exposure for Transmission to DKO Mice 
 Mosquitoes were offered an infectious blood meal 3-5 days post emergence with an 
infectious titer of 106 pfu/ml. The blood meal consisted of bovine blood in Alsevier’s anticoagulant 
(Hemostat, Dixon, CA) mixed 2:1 with a virus solution in a total volume of approximately 3 ml per 
carton, heated to 37°C and kept warm via the Hemotek device (Discovery Workshops, Arrington, 
Lanceshire, UK). Mosquitoes were allowed to feed for 45 minutes before the blood meal was 
removed. Each carton consisted of 100 mosquitoes and 7 cartons were fed for this study. Mosquitoes 
were then sorted and only fully engorged females were kept; all others were discarded. 
Approximately 50% of mosquitoes were females, and there was approximately 100% successful 
feeding. Thus, approximately 350 engorged females were identified by the presence of red blood in 
the abdomen, visible with the naked eye. Seven mice were anesthetized with isoflurine and placed 
on top of each carton of dengue 2 (strain 1232) exposed mosquitoes. (Thus, each mouse was exposed 
to approximately 50 potentially infectious mosquitoes.)  Mosquitoes were then tested for presence of 
virus in the legs as a proxy for disseminated infection.  Testing was done via qRT-PCR on the Roche 
LightCycler 480 as previously described (Christofferson and Mores 2011). 
 
Transmission from Viremic Mice to Mosquito 
 Mice were inoculated with 105 pfu/mouse D2 1232 via needle inoculation as above. (n=3)  
Every day post exposure, mice were anesthetized and placed on top of cartons of naïve mosquitoes 
approximately 3-4 days post emergence.  Mosquitoes were allowed to feed for approximately 15-20 
minutes and then the mice were removed.  Engorged females were separated and placed in clean 
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cartons and kept at constant environmental conditions (16:8 hours light:dark, 28°C, 70-80% 
humidity).  Whole mosquito bodies were tested for the presence of virus 3 days post exposure to 
determine infection (not dissemination) status. 
 
Cytokine Measurement and Statistical Analysis 
 IFN-	  γ,	  TNF-­‐α, IL-4 and IL-1β were measured using the Millipore Milliplex MAP Mouse 
Cytokine/Chemokine kit as per manufacturer’s instructions (Millipore, Billerica, MA). Viremia and 
cytokine levels were analyzed using a mixed linear model with repeated measures. All analyses were 
performed in SAS 9.13 (Carey, NC). Significance was detected at the α=.05 level. 
 
Results 
Successful Transmission in IRF3/7 DKO by Subcutaneous Needle Inoculation 
 Transmission of virus via subcutaneous needle inoculation was successful in 100% of the 
DKO mice while no viremia was detected in the control mice challenged with D2 16803. Viremia 
levels were centered on the day of peak viremia (P0).  Days before and after peak viremia were 
labeled relative to peak viremia: two days before peak day (P-2), the day before (P-1), peak day (P0), 
the day after peak (P1) and where relevant, two days after peak (P2). Mean viremia levels for each 
viremia day was calculated for each treatment group.  Since no viremia was detected, the first day 
post-exposure was considered the day after peak viremia day.  
There were significant differences in viremia intesntiy detected among all three strains of 
dengue.  Mice infected with D2 1232 had the highest viremia at all time points followed by D2 
16803 and lastly, D4 LN 634441. In addition, mice infected with D2 1232 had detectable viremia for 
four days while mice infected with either D2 16803 or D4 LN 634441 had only two days of viremia 
(Figure 5.2).   The ability to achieve 100% infection using natural levels of virus inoculum from  
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Figure 5.2: Mean viremia levels of dengue infections. Mean viremia levels are centered around 






three unadapted dengue strains of two serotypes is an important step towards studying transmission 
of dengue, and is a first in dengue transmission research. 
 The type II interferon response to these dengue strains was investigated to determine whether 
any correlation existed between successful transmission. Across all dengue strains, INF-γ peaked on 
peak viremia day (P0), though no significant differences were observed between this and the day 
after viremia peak day across treatments. There was a statistical difference in IFN- γ levels between 
D2 16803 and the other two strains, while D2 1232 and D4 634441 differed only at time points P-2 
and P0.  Since the controls do not have times points before P1, only that day was considered and it 
was statistically different from all three strains (Figure 5.3). Consistently, two days after peak INF-γ 
levels, viremia was either cleared (D2 16803, D4 LN) or drastically reduced (D2 1232).   
 The most robust IFN-γ response was noted in mice infected with D2 16803.  These levels 
peaked on P1 with levels over 200 times more than the controls on that day. There is a lack of direct 
correlation between relative viremia intensity and the IFN- γ response.  That is, the highest levels of 
viremia did not elicit the highest or the lowest IFN- γ response and vice versa.  
 The TNF-α responses across dengue infected DKO mice did not differ except on day 
P1where D2 16803 appeared to be significantly higher than the other groups. Again, only P1 data is 
available for the control mice, but it does not appear that controls differed from D2 1232 or D4 
LN634441 infected mice (Figure 5.4).  IL-1β did not differ across any times points for any 
treatments and was largely undetectable. 
 Though the controls did not have detectable viremias or significant IFN- γ or TNF- α 
responses, they did produce significantly higher levels of IL-4 at time points P1-P4 (Figure 5.5).  
Because of the sampling regime this could be due to true differences in the reaction of controls 
versus DKO mice, or it could be that the IL-4 response in the DKO mice was not detected since we 
did not sample those mice that many days post infection.  Additionally, the variability among the  
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Figure 5.3: IFN-γ response of infected and control mice.  D2 16803 infected mice elicited the 



























Figure 5.4: TNF-α response in dengue infected and control mice. The TNF-α response was not 
significantly different over most time points, but on P1 D2 16803 did differ from the controls and 
from the other two strains.  Error bars cannot be seen for some of the time points because the 
standard errors were so small. 
 
 
Figure 5.5:  IL-4 responses in dengue infected and control mice. The IL-4 response of D2 1232 
and D4 LN 634441 did not differ significantly, except for on P-1.  D2 16803 did not elicit an IL-4 
response during the sampled time points.  The control mice had a comparatively higher IL-4 
response at later time points, though this could be because of how we assigned time post peak 












































control mice constrain this analysis somewhat, though further investigation to specifically compare 
IL-4 to DKO would be interesting. 
 
Mosquito versus Needle Transmission 
 To discern whether the roles of type I and type II interferon in dengue transmission is 
different when mice are exposed via infected mosquitoes, we inoculated seven mice by infected 
mosquito with D2 1232. Of the 7 mice exposed to infectious mosquitoes, 100% developed viremia. 
The day of peak viremia and the viremia titer on those days was not dependent on the number of 
infectious mosquitoes to which the mice were exposed (p>.05). The day of onset of viremia, 
however, was dependent on the number of infectious mosquitoes transmitting virus (p<.05). The 
average peak viremia was 7.14x102 pfu/ml (min. 3.0 x 101 pfu/ml, max. 2.15x103 pfu/ml). These 
results are summarized in Table 5.1. 
 Viremia levels in mosquito inoculated mice were statistically higher than those of the needle 
inoculated mice at all times except peak viremia (P0) (Figure 5.6). In addition, mosquito inoculated 
mice had detectable viremia for five days as compared to the needle inoculated mice, which had only 
four days detectable viremia.  This also indicated that viremia peaked on average one day later post-
exposure, though this was affected by the number of inoculating mosquitoes, as discussed above. 
As in the needle inoculated mice, IFN-γ production rose significantly on P1, and this day represented 
the only statistical difference between the groups in IFN-γ response (Figure 5.7). Between the needle 






Table 5.1:  Summary of transmission from mosquito to IRF DKO mice. *Indicates peak day for 








1 dpi 2 dpi 3 dpi 4 dpi 
251 6 0 1.99 1.94e2 1.060e3 4 
252 5 0 1.5e1 5.98e1 6.86e2 4 
253 1 0 0 4.12 3.0e1 4 
267 2 0 0 657 3.15e2 3 
268 9 0 3.3 2.58e1 2.78e2 4 
269 5 0 9.82 1.58e2 2.150e3 4 




Figure 5.6: Viremia levels of mosquito vs. needle inoculated DKO mice. Viremia in mosquito 
inoculated mice was detectable for one day more than needle inoculated mice (5 days vs. 4 days, 
respectively). Viremia levels between the two treatment groups were statistically different at all 







Figure 5.7: IFN-γ response in needle inoculated vs. mosquito inoculated infections. The IFN-γ 
response differed significantly on days P1 of infection and an additional day of IFN- γ was detected 



























IRF3/7 -/- -/- DKO Mouse Supports Transmission to Naïve Mosquitoes 
 Viremic mice supported acquisition of virus by naïve mosquitoes on days P-1 and P0.  Two 
of the three mice on day P-1 supported acquisition and on P0, again two mice supported acquisition, 
though only one mice supported acquisition on both days. Acquisition percentages were 7.14% (2 




 We confirmed that this mouse is a successful and novel model of dengue transmission.  It has 
the ability to support non-adapted dengue strains of at least 2 serotypes and can be used to test for 
differences in infection kinetics in a vertebrate host. In addition, it can be used to study the natural 
routes of transmission: infected mosquitoes. Importantly, we determined that the absence of the type 
I interferon is critical for establishment of dengue infection and thus a successful transmission event. 
Type II interferon, while necessary for viral clearance, is apparently not responsible for the 
inhibition of dengue infection establishment. In other words, given that transmission was 100% 
blocked in mice with an intact type I interferon response, and that when this response was abrogated, 
100% infection was achieved. We conclude that type I interferon response is the critical response 
mitigating successful transmission of dengue virus.  Also, given that in the control mice no viremia 
was detected and only a weak, limited IFN-γ response was elicited, and given that in the DKO mice 
the IFN-γ response was so temporally associated with cessation of viremia, we conclude that type II 
interferon response is necessary for and sufficient to clear dengue infection. 
 In addition, we determined that while mosquito salivary secretions have been known to alter 
the interferon responses, it does not change the relative importance of the systemic type I versus type 
II response. That is, type II still did not play a role in the initial establishment of infection while the  
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Figure 5.8: Mean viremia levels of mice (n=3) from which acquisition to mosquitoes was 
attempted. Mice were inoculated with 105 pfu/mouse of D2 1232.  Each day post exposure, 25-50 
mosquitoes were allowed to feed.  Engorged females were kept and tested 3 days post feeding for the 
presence of virus in the body (i.e. infection, not dissemination).  Acquisition of virus was achieved 






absence of the type I response allowed for successful transmission via infectious mosquito. While 
some differences were noted in the IFN-γ response in mosquito versus needle inoculated mice (later 
peak of viremia and IFN-γ), the significance of these differences needs further study. In addition, the 
mechanistic origins of these differences, whether based on mosquito saliva or some intrinsic 
vertebrate or viral characteristic, requires investigation. An important limitation of this particular 
result is the measurement of systemic cytokine levels. Likely even more significant alteration of the 
immune response due to mosquito salivary secretions would be seen at the bite site, and not 
necessarily systemically. Therefore, it is important to continue to investigate the potential role of 
mosquito saliva in infection kinetics.  
 We also present, based on our findings, the concept of “effective viremic period” (EVP).  
That is, there exists a subset of the viremic period where transmission is unlikely.  The EVP is the 
subset of the viremic period where transmission to a vector is probable. This is presented in Figure 
5.9, where the acquisition rates from D2 1232 infected mice on days P-1 and P0 were 6% and 11%, 
respectively. The value of EVP would have a dramatic effect on calculations of the basic 
reproductive number (R0), which includes a specific parameter encompassing the length of viremia 
(or, reciprocally, recovery rate). Possibly even more importantly would be the interaction among the 
parameters of EVP, intensity of viremia (c), and an acquisition parameter (q). Likely, the most 
critical parameter would be acquisition, as it measures the direction transmissibility resulting from 
the other two measures. Ultimately, it isn’t the absolute values of length and intensity of viremia, but 
whether a critical threshold is achieved which supports transmission to a naïve vector and how long 
viremia persists above that threshold. 
 In addition to allowing for transmission and infection establishment, this mouse model also 
has the ability to discern strain differences among dengue viruses. This makes it an ideal candidate 
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for viral fitness studies that could inform vaccine efforts. The three strains of dengue used here 
produced differential patterns of viremia and IFN-γ response. D2 1232 produced the highest viral  
 
Figure 5.9: Illustration of the effective viremic period. Mean viremia levels for mice infected with 
D2 1232 (n=3) and the successful acquisition of virus by mosquitoes. In a D2 1232 infection, the 
actual viremic period lasts for four days. However, acquisition of virus from the mouse by a 
mosquito occurs only on two days as denoted by the green square. Thus, the effective viremic period 






effective viremic period 
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titer and longest viremic period suggesting it is the most fit of the three strains. This is especially 
interesting since this strain is also shown to be the most fit in the mosquito (Christofferson and 
Mores 2011). Infection with D4 LN 634441 resulted in the lowest viral titers in the serum. It is also 
interesting that the highest levels of INF-γ were not seen in the infection causing the highest viremia. 
This suggests that D2 1232 has some fitness advantage in that it does not elicit or somehow 
mitigates the INF-γ response, perhaps independently of the type I interferon pathways. As stated, the 
highest levels of INF-γ were detected with D2 16803 infection, and if the INF-γ response and 
viremia levels were monotypically correlated, the expectation would be that D4 LN 634441 would 
have the lowest INF-γ levels on peak days. This, however, is not the case, as D2 1232 has the lowest 
peak day IFN- γ levels. D2 16803 cumulatively elicited the highest levels of INF-γ, which was most 
likely the reason for the truncated viremic period.  
 There are, then, two possible interactions of viremia and INF-γ response. First, a viral strain 
like D2 1232 has evolved a fitness advantage to escape the INF-γ response which then allows for the 
higher viremia intensity and longer viremic period. Second, strains like D2 16803 and D4 LN 
634441 do not have this fitness advantage. Therefore, the IFN- γ response occurs quickly, which is 
likely the reason for the truncated and lower viremia levels.  
 The fact that virus was no longer detectable following the peak of INF-γ	  reaffirms the 
importance of this response in the clearance of dengue virus infection (Chaturvedi, Elbishbishi et al. 
1999; Green, Vaughn et al. 1999). This response mirrors the correlation between INF-γ response and 
viremia disappearance seen in children with dengue (Green, Vaughn et al. 1999; Chen, Yeh et al. 
2001). This shows the ability to use this mouse model for inferences about dengue and its infection 
of humans. Further, this model highlights the role of the elicited INF-γ response in assessing viral 
fitness. In addition, the significant differences in the INF-γ response also indicates that even low 
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levels of viremia and the seemingly small differences in these low viremia levels may be 
biologically important.  
 Further fitness studies could also include differential responses to type I interferon. Since the 
IRF3/7 DKO mouse has an intact interferon receptor, IFN α/β can be exogenously introduced at 
different dosages in order to detect differential ability of DENV serotypes/strains to modulate and 
escape the antiviral immune response. Here we demonstrate the use of this DKO mouse model to 
detect differences in viral fitness in a vertebrate model among 3 DENV strains by comparing the 
infection establishment success and replicative abilities (viremia intensity). The importance of 
dengue viral fitness in understanding transmission dynamics is not only important in understanding 
dengue disease patterns, but in understanding the potential of different strains for use in vaccines. 
 Given that there is no vaccine, public health monitoring and a greater understanding of 
transmission dynamics leading to outbreak events is the first line of defense in the fight against 
DENV. The infection kinetics that mitigate the transmission of DENV from the vertebrate, namely 
the length and intensity of viremia, are crucial to understanding transmission. Part of the kinetic 
differences is the virus’ ability to escape the antiviral immune response, specifically to modulate the 
type I interferon response. This ability cannot be tested in a receptor deficient mouse as no type I 
interferon response is possible. This mouse model offers the unique ability to use non-lab adapted 
strains to more accurately assess the true relative fitness of dengue strains. In addition, since this 
mouse retains the receptors for type I interferon, there remains the opportunity to assess the type I 
interferon responses elicited by dengue strains by exogenous introduction of type I interferon. 
Additionally, this mouse allows us to assess the immune response in a vertebrate model that is as 
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 Much work has been done on genotypic studies of arboviruses, including West Nile virus 
(WNV), dengue (DENV), and chikungunya (CHIKV) (Lanciotti, Roehrig et al. 1999; Ebel, 
Carricaburu et al. 2004; Jerzak, Bernard et al. 2005; Schuffenecker, Iteman et al. 2006; Bertolotti, 
Kitron et al. 2008; Jarman, Holmes et al. 2008; Kariuki Njenga, Nderitu et al. 2008; Santhosh, Dash 
et al. 2009; Carrillo-Valenzo, Danis-Lozano et al. 2010; Mendez, Usme-Ciro et al. 2010; Papa, 
Bakonyi et al. 2011). In the study described in Chapter 2, we showed that WNV genetic diversity 
was negatively correlated to transmission increases. Other researchers have shown that DENV 
diversity is positively associated with increases in transmission. Still, other studies have 
demonstrated that CHIKV has relative genetic stability even during intense transmission (Bertolotti, 
Kitron et al. 2008; Jarman, Holmes et al. 2008; Kariuki Njenga, Nderitu et al. 2008; Christofferson, 
Roy et al. 2010). These contradictory studies show that the association of genetic diversity and 
transmission is complex and unclear and suggests that rough measures of genetic diversity are 
insufficient to predict virus transmission differences. One possibility is that the phenotypes encoded 
by these genotypes are able to explain these differences and a more rigorous characterization of 
these traits could improve our forecasting of viral activity.  
 Extrinsic and environmental factors can affect phenotypic expression as seen in Chapter 2 
where ecological niche also contributed to transmission differences and genetic diversity. 
Comparisons of viral fitness among different strains or species of arboviruses have been 
investigated, while the differences among cocirculating strains within a given focus and the effects 
on transmission of those strains have not been vigorously investigated. Presented in this dissertation 
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are four experimental studies that explore the contribution of differential phenotypes to the 
transmission potential of arboviruses as judged by modeling parameters such as vectorial capacity 
(VC) and the basic reproductive number (R0). In this chapter we show the interrelatedness of these 
studies and the general conclusions. Additionally, future directions of this research are offered as 
well as continued utilization of the tools developed through this research. 
 
Summary of Results 
The study of West Nile virus in Louisiana (Chapter 2) prompted an interest in the potential 
role of strain differences in transmission potential. We noted that there was differential transmission 
among ecological settings, which was not totally surprising given the possible extrinsic factors 
affecting transmission (bird species richness, temperature, humidity, etc.). What was compelling 
were the differences in genetic diversity seen within ecologies, i.e. the wetland ecology predicted to 
have higher transmission (wetlands) had less diversity than did the forest ecologies.  
 Coincidentally, at the time we were contemplating the role of strain differences, Jarman, et 
al. published a paper detailing the transmission of dengue among eleven schools in a region of 
Thailand (Jarman, Holmes et al. 2008). They reported no clear correlation between genetic diversity 
changes in transmission of dengue fever (Jarman, Holmes et al. 2008). This lack of clear association 
between genetic diversity and transmission led to our hypothesis that the phenotypic differences, not 
just major phylogenetic characteristics are critical factors driving the transmission of arboviruses.  
 The studies in Chapters 3-5 of this dissertation address the parameters of the R0 equation in 
order to achieve a dynamic, more accurate measure of the transmission potential, and thus epidemic 
potential of arboviruses. Chapters 3 and 4 address the vector parameter- vectorial capacity (V). 
Chapter 5 addresses the vertebrate parameters of intensity of viremia (c) and recovery rate (1/r) (or, 
reciprocally, length of viremia). 
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 The equation for R0 is given below: 
     R0 = cV/r      Eq. 6.1 
 
 In Chapter 3, we undertook to assess how differences in phenotypes in the vector could alter 
transmission. We chose three virus strains from the Southeast Asian genotype of dengue type 2, as 
well as a Southeast Asian dengue type 4 to illustrate our theory. We found that strain differences can 
potentially affect the transmission potential. For example, as we show in Table 3.4 that while D2 
1232 could potentially result in 32 secondary infectious bites, D2 16803 would result in only 28 
secondary infectious. The significance of this difference is discussed in detail below. Of importance 
is the formulation of effective vector competence (EVC) and cumulative vectorial capacity (cVC), 
which provide more accurate assessments of viral fitness within mosquito vectors. In addition, we 
provide a statistical test of vectorial capacity (cumulative) where none existed before.  
 Further, the idea that phenotypic advantages in vivo could alter vectorial capacity in mosquito 
species led us to consider a potential two vector system (Chapter 4). Such a system is exemplified by 
CHIKV where in 2006, a genetic shift conferred a fitness advantage in a traditionally secondary 
vector, Aedes (Ae.) albopictus. However, Ae. aegypti could not be discounted as a vector of this new 
genotype. Using the novel EVC formulation we showed that on La Reunion Island, there was a 
significant fitness disadvantage in Ae. aegypti. However, the dynamics of this mutation on that 
island where Ae. aegypti is absent did not fully explain the spread of the mutant strain across India 
and into Southeast Asia where Ae. aegypti and Ae. albopictus coexist. Given that CHIKV has been 
relatively stable in these areas regardless of the presence of Ae. albopictus, it is unlikely that 
selection pressures for that vector alone could have driven the expansion of this mutant. This is 
further supported by the finding that the E226V mutation conferred no apparent fitness advantage in 
the vertebrate (Bordi, Meschi et al. 2011; Tsetsarkin, Chen et al. 2011). Therefore, using our EVC 
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method we experimentally investigated and confirmed that the E226V mutant strain had a significant 
advantage in Ae. aegypti relative to a likely resident CHIKV strain while there was a slight, but 
statistically significant disadvantage in Ae. aegypti as compared to the pre-mutation strain found on 
La Reunion island. Thus, some selection process that occurred in the presence of both vectors, and 
not just a scenario of Ae. albopictus (as on La Reunion Island) likely contributed to the expansion of 
this particular mutation. This illustrates that the relative in vivo, within vector phenotype can aide in 
explaining an expansion phenomenon where genetic analysis has been less informative. 
 Given these two chapters and the validation with known historical events (see Chapter 3, 
Discussion), we have reformulated the parameter V into cVC: 
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where: 
    φ = EVC = p! β!"N+   β!" dN
!
!     Eq. 6.4 
 
 These results illustrated that even seemingly small phenotypic changes have the potential to 
significantly alter the relative transmission of cocirculating strains.  Investigation of phenotypic 
differences in the vector is logically followed by a similar investigation in the vertebrate.  
Specifically, dengue virus usually exists in a hyperendemic situation where multiple serotypes and 
multiple strains within those serotypes cocirculate.  Confounding studies of phenotypic differences 
as related to transmission was the lack of a transmission model for dengue in a small animal. 
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 Therefore, our first undertaking was to identify and test a mouse model with the intention of 
studying not disease, but transmission of dengue virus.  We chose the interferon regulatory factor 
(IRF) 3 and IRF 7 double knockout mouse strain since it is deficient in the type I interferon response 
(Daffis, Suthar et al. 2009).  This murine model allows for strain comparisons in both viremia and 
immunological response, especially the IFN-γ response.  The widely used AG129 mouse cannot 
support IFN-γ hypotheses as it is unable to mount an IFN-	  γ response (Shresta, Sharar et al. 2006; 
Yauch and Shresta 2008). In this study we showed a discordant relationship between viral fitness as 
measured by length and intensity of viremia and the immunological response. It was expected that 
the higher and/or longer viremia would elicit a stronger immune response, especially type II 
interferon because of the correlation seen between IFN-	  γ and disease state (Becquart, Wauquier et 
al. 2010; Tang, Kou et al. 2010). However, the highest and longest viremia did not cause the highest 
or longest IFN-	  γ response. In fact, the length of the IFN-	  γ response did not differ much among the 
three strains of dengue viruses. The more robust IFN-	  γ response was seen in those mice infected 
with D2 strain 16803 which had neither the highest nor lowest viremia. It is possible that this viral 
strain has an added advantage of being able to subvert the IFN-	  γ response, but the exact role of this 
and its relationship to viral fitness remains to be explored. 
 We are also the first to show that DENV transmission to and from a mosquito is possible in a 
small animal model. Within this model we also introduce the concept of effective viremic period 
(EVP), a subset of the traditional measure of viremic period used to calculate R0. By having a mouse 
model with the ability to support studies of transmission and acquisition by the natural vector route, 
and, using this EVP measure, the calculations of R0 should be enhanced as assumptions of the 
acquisition success rate by mosquitoes can now be investigated.  
 The relationship of intensity and length of viremia with respect to mosquito-borne viruses 
would logically imply some function of acquisition. However, there is not a formulation of R0 that 
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includes any such parameter. Such an acquisition parameter (q) would be defined as the proportion 
of mosquitoes, which become infected after feeding on a viremic animal. To illustrate how a final 
formulation of R0 may look we determine the relationship among acquisition (q), intensity (c), and 
length of viremia (r). 
 In Chapter 3, we found that D2 strain 1232 has a cVC of ~32. This is interpreted in the 
following manner:  Over the course of 9 days (the total extrinsic incubation period measured), D2 
1232, in a population of mosquitoes where the contact parameters of man biting rate and mosquito 
density remain constant, will result in 32 infectious bites to humans. In Chapter 5 we showed that in 
the mouse model, D2 1232 resulted in 4 days of detectable viremia. However, we further 
demonstrated that the EVP was, in fact only 2 days and that acquisition at viremia days P-1 and P0.  
We postulate that a complex relationship exists among the differential phenotypes 
represented by these parameters. Namely, there exists a threshold of viremia above which 
acquisition is possible. This threshold intensity would identify a subset of the viremic period, 
defining the EVP. The intensity of viremia within this EVP would then correlate to some function of 
acquisition. This is illustrated in figure 6.1. For example, with D2 1232, the threshold of viremia 
intensity is defined by acquisition, and this threshold will then create a subset of the viremic period; 
the EVP where acquisition is probable. Likely, the parameters of intensity and length of viremia, as 
they are directly and positively correlated to acquisition, will be replaced by the acquisition 
parameter itself. Then, a function of acquisition over time, similar to the function devised in Chapter 
3 for vector competence over time, could be developed.  
  In the case of D2 1232, the cumulative acquisition (qc) is easily obtained by simple addition, 
since only two points of acquisition exist, and thus is calculated to be 17%. However, if the 
relationship were to become more complicated, a higher order function would be needed to define 


































































Figure 6.1: A more complicated relationship. A) A threshold is determined and then B) the EVP defined. 
The distribution of acquisition is also determined for the EVP based on the intensities. C) The area under the 
curve q(EVP) is a possible way to calculate the cumulative acquisition, and thus the cumulative transmission 





possibility if viremia were to last 12 days, but only days 2-10 were high enough to support the 
probability of acquisition. 
Using the formulations from these studies, R0 could have the following form: 
 
  R0c = qc * EVC * 
!!!
! !"!
     Eq. 6.5 
 
 
Or, by combining the contact parameters and EVC into cumulative vectorial capacity: 
 
R0c = qc *cVC       Eq. 6.6 
 
 This measure of cumulative R0 would be interpreted over the period of days defined as the 
number of days of the mosquito extrinsic incubation period (the interval over which EVC was 
integrated), and the total number of viremic days. This is because, while no actual transmission is 
occurring during those days of the viremic period where acquisition is improbable, those days are 
equally as important in assessing the timing of potential outbreaks. This is especially so when 
comparing viral strains and assessing fitness as time to adequate viremia could be considered a 
measure of fitness itself.  
 To further simplify the interpretation, and since R0 is traditionally defined as a measure of 
transmission per day, the measure of transmission per day can be derived by simply dividing R0c by 
the total number of days in the transmission cycle. In the case of D2 1232, the extrinsic incubation 
period measured within the vector was 9 days. In the vertebrate there were a total of 4 viremic days, 
therefore the total transmission cycle could theoretically be calculated as 9+4 = 13 days. Thus, using 
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  = .41    Eq. 6.7 
 
Given the definition of R0, since this estimate is less than 1, the risk of an outbreak is not 
probable. This is a conservative estimate of R0 in that for this particular study, only the exponential 
phase of vector competence was utilized. Additionally, the viremia levels achieved by the mouse 
model are assumed to be proportional to, but not exact replicas of viremia levels in humans which 
can reach up to 107 pfu/ml. However, investigations into the proportionality of the mouse to human 
viremia can be made and the information garnered about the relative parameters of strains can still 
be used to model transmission differences. 
 
Conclusions 
 Fitness of arboviruses has been hypothesized to be constrained by the requirement of two 
main hosts: vector and vertebrate. This idea was first proposed by Taylor and Marshall in 1975 using 
Ross River virus (Taylor and Marshall 1975; Taylor and Marshall 1975) and hypothesizes that 
extraordinary fitness in either the vector or the vertebrate is “traded” for adequate fitness in both. 
This “trade-off hypothesis” has been studied in several arboviruses both in vivo and in vitro 
(Cologna, Armstrong et al. 2005; Greene, Wang et al. 2005; Ciota, Lovelace et al. 2007; Coffey, 
Vasilakis et al. 2008; Moutailler, Roche et al. 2011). However, the measurements of fitness are often 
conservative and we show that even small changes can alter transmission potential.  
We show that the contribution of infection kinetics in the vertebrate to the formulation of R0 
is one of a dilution effect. That is, acquisition is a proportion that will further subdivide the 
population of mosquitoes into those that will likely transmit and those that will not. It would 
therefore seem likely that even small fitness advantages in the vertebrate (that raise either q or 
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lengthen EVP) would have profound effects on the transmission potential of that viral strain. It might 
be that the trade-off hypothesis is a misrepresentation of the importance of small changes. That is, 
while big shifts in fitness in either host would compromise overall fitness in both hosts, big shifts are 
not necessary for advantages to appear.  
 An example of how these two fitness scenarios could potentially yield a new formulation of 
R0 is proposed, but final validation will likely involve a more complex relationship and is beyond 
the scope of this dissertation. However, we do illustrate that the possibilities exist for phenotypic 
changes, even when relatively small, have the potential to affect transmission dynamics. This idea 
could have profound effects on the trade-off hypothesis as well as applied studies of transmission 
and public health policy. For example, whether an epidemic is being driven by strain fitness in the 
vector or in the vertebrate could decide whether mitigation of the outbreak could best be controlled 
by vector control strategies or by human behavior modifications. 
 In summary, this dissertation proposes that phenotypic variation is at least as important, if not 
more important, for assessing transmission potential of arboviruses than genotyping alone. Further, 
we offer a more accurate tool for assessing transmission potential in the vector and provide a new 
model assessing transmission potential in the vertebrate. While this dissertation does not propose a 
finalized, dynamic formulation of R0- the ultimate transmission estimate- it provides several of the 
necessary steps towards a more appropriate calculation. Furthermore, one of the major objectives of 
our studies is to provide not only these more accurate formulations, but to provide accessible 
parameters and calculations. In conclusion, our use of R0 provides a framework for a more dynamic 
formulation of transmission models and provides such an accessible framework for output validation 
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Appendix	  3	  
	  
EVC	  and	  cVC	  SAS	  Code,	  Single	  Phase	  
	  
/**********************************EVC_cVC calculations Part 
1*****************************************/ 
/****This part of the program simulates all bootstrap data and 
calculates the linear function b(N)****/ 
/****The integration and EVC, cVC calculations are in Part2 ***/ 
 




if strain="LR06" then n=15; 










if strain="SEA" then output; 
run; 
 
/*THIS MACRO IS FOR BOOTSTRAPPING WITH PROC SURVEYSELECT, SELECTION 
WITH REPLACEMENT*/ 
/*Go me and my bad programming self*/ 
/*sx= sample size for timepoint=x)*/ 
%macro samp_wr (data, s1, s2, s3, num); 
ods listing close; 
%do g=1 %to &num %by 1; 
 proc surveyselect data=&data outseed method=pps_wr sampsize=(&s1, 
&s2, &s3); 
 size n;  
 strata strain dpi; 






%samp_wr (LR, 15, 15, 15, 1001); 
%samp_wr (SEA, 16, 16, 16, 1001); 
 
/*COMBINE MACRO CREDIT:UCLA website- 
http://www.ats.ucla.edu/stat/SAS/code/mac_set.htm*/ 
/*Modified by me*/ 
%macro combine (id, start, stop); 
data big&id; 
  set 
  %do i = &start %to &stop %by 1; 
    data&i 
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  %end; 
  ; 
run; 
%mend; 
%combine (LR, 1, 1001); 




/*Double checking the data to make sure the surveyselect worked 
properly*/ 
/*InitialSeed is now the ID of each boostrap*/ 
/* AN ID=1 INDICATES ORIGINAL DATA SET*/ 
data big; set bigLR bigSEA; run; 
proc sort data=big; by strain dpi InitialSeed; run; 
proc means data=big sum; 
var NumberHits; 
by strain dpi InitialSeed; 
run; 
 
data biglr; set biglr; rename InitialSeed=ID; run; 
data bigsea; set bigsea; rename InitialSeed=ID; run; 
data Lr; set Lr; ID=1; run; 
data SeA; set SeA; ID=1; run; 
 
/*Getting the calculated vector comp. values = total positive legs/ 
total tested */ 
/*THIS IS DONE ON THE ORIGINAL DATA AS WELL AS BOOTSTRAPPED DATA*/ 
%macro b (data); 
proc sort data=&data; by dpi ID n; run; 
ods listing close; 
proc means data=&data; 
by dpi ID n; 
var diss; 















/*A NEW ID NEEDS TO BE ADDED TO THE BOOTSTRAPPED SAMPLES SO THAT THERE 
IS A SET OF IDs NOT JUST PER DPI*/ 
data NID; 
 do i=2 to 1002 by 1; 
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data NID3; set NID NID NID; run; 
 
%macro ID (data, original, new_data); 
data &data;  












set &data &original; 




%ID (sbiglr, slr, LR06); 
%ID (sbigsea, sseA, SEA); 
 
/*DOING REGRESSION TO GET THE LINEAR FUNCTION OF B(N)*/ 
/*THERE IS ONLY THE E-PHASE, SO ONLY 1 LINE IS NEEDED*/ 
%macro reg (data, id); 
ods listing close;  
proc sort data=&data; by ID; run; 
proc reg data=&data outest=reg&id; 
by ID; 
ID=ID; 
model b=dpi / cli;  
run; quit; 
%mend; 
%reg (LR06, LR); 






























/**************************EVC_cVC calculations Part 
2******************************/ 
/****This part of the program performs the integration and EVC, cVC 
calculations***/ 
 
libname chik "C:\Users\ODP\Desktop\SCHOOL\papers\ChikV"; 
 




if strain="LR06" then N=15; 
else if strain="SEA" then N=16; 
run; 
 
proc sort data=reg; by strain ID dpi; run; 
 
/***dataset all has the simulated data for 1000 bootstraps with 
replacement + the original data***/ 
/***data has the following variables:  strain, ID (bootstrap ID), 
dpi (day post exposure),  
          n (at each 
dpi/strain), and b (dissemination rate)********/ 
/***IMPORTANT to know which ID corresponds to the original experimental 
data, as this will need to be extracted 




/* COMPUTATION OF THE AREA UNDER THE CURVE: 
 
Area (Ahat) = (m(a^2)/-ln p) * integral(lower to upper) {p^N * b(N)} dN 
  = (m(a^2)/-ln p) * integral(lower to upper) {p^N * 
(beta1(N) + beta0)} dN 
  = (m(a^2)/-ln p) * [ beta1 * integral(lower to upper) {p^N 
* N} dN + beta0 integral(lower to upper) {p^N} dN] 
  = (m(a^2)/-ln p) * c0*Beta0 + c1*beta1 
Where 
  
 Bmatrix (Bhat)= (b0 b1)' = [(X'X)^-1 * X' * p-hat] 
 p-hat = [p1 p2 p3]'  where pi= proportion at time i 
 X=[1 t1 
       1 t2 
       1 ti]  where ti are the time points of interest 
    (t1 would be lower limit, ti would be upper 
limit of intergral) 
 
 c0 = integral(lower to upper) {p^N} dN = [1/(log p) ] * 
[p^N_upper bound - p^N_lower bound] 
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 c1 = integral(lower to upper) {p^N * N} dN = [1/(log p)^2 * 
(p^N_upper * (N_upper* log p) - p^N_upper -  
            
 p^N_lower * (N_lower * log p) + p^N_lower)] 
 
*/ 
/*Using Trapezoidal Approximation for Area Under the Curve*/ 
/*Macro by Rebecca Christofferson*/ 
%macro auc (a, b, n, function, j); 
data is; 
cx= ((&b-&a)/&n); 
 do i = 0 to &n; 
 put i; output; 
 end; 




if i=0 then x=&a; 
 else if i=&n then x=&b; 





if i=0 then fx= (&function/2); 
 else if i=&n then fx= (&function/2);  
 else fx= (&function); 
run;  
 
proc sort data=x&j; by i; run; 
proc sort data=fx&j; by i; run; 
 
data data&j; 




proc summary data=data&j; 
var fx; 













/******SINCE ALL IN THE SAME MOSQUITO VECTOR, DO NOT NEED STRAIN 
SPECIFIC QUANTITIES IN THIS PART********/ 
/******This is done on a per strain-ID basis******/ 
%auc (3, 7, 150, (.91**x), c0); 
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%auc (3, 7, 150, ((.91**x)*x), c1); 
/***These give quantities of the two matrices above****/ 
 
data c_matrix; 
set areac0 areac1; 
run; 
 
/***Since I am holding constant m and a, arbitrarily assigned them a 
value of 1***/ 
/*** The daily survival probably .91 is from: 
  Harrington LC, Buonaccorsi JP, Edman JD, Costero A, 
Kittayapong P, et al. (2001)  
  Analysis of survival of young and old Aedes aegypti 
(Diptera: Culicidac) from  
  Puerto Rico and Thailand. J Med Entomol 38: 537-547. 
***/ 
data constants; 
input m a p; 
datalines; 
1 1 .91 
; 
run; 
data constants; set constants; const=m*(a**2)/ -(log(p)); run; 
 
/*********Estimates of the Variance**********/ 
/*  Variance (Ahat) = (constants^2) * (C0 C1)*Var(Bhat)*[(Co C1)'] 




 Variance (Bhat) = [(X'X)^-1]*X'*[diag(var p-hat-i)]*X*(X'X)^-1 
 
where 
 var (p-hat-i) = [ p1(1-p1)/n1    0     0 
        0    p2(1-p2)/n2 
        0    0 
 pi(1-pi)/ni] 
 
*p has a binomial distribution; thus the binomial variances* 
***********************************************************************
********/ 
/*variance matrix calculations*/ 
proc sort data=chik; by strain ID dpi n; run; 
data m; set chik; 
var=b*(1-b)/N; *binomial variance computation where b=p; 
run; 
 
/*seperating each strain into its own dataset*/ 
%macro sep (dataset, set, var, condition); 
data &dataset; 
set &set; 




%sep (sLR06v, m, strain, "LR06"); 
%sep (sSEAv, m, strain, "SEA "); 
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%macro var (dataset, n, firstobs, label); 
data s; set &dataset; run; 
proc sort data=s; by ID dpi; run; 
%do i=1 %to &n %by 1; 
proc iml; 
/*reading my variances calculated in the data step above*/ 
/*vp is my variance of p, where p= my b values (proportions)*/ 
/*variances calculated as binomial p(1-p)/n */ 
start var(varp1, varpsub, vp, x, xpx, vbhat, vb2, vb3, vb4); 
 use s; read all into varp1 var{var}; create checkvp from varp1; 
append from varp1; 
 varpsub=varp1[1:3];  print varpsub; 
/***********The varpsub matrix will need to be changed if a different 
number of time points are used 
   EXAMPLE: for 4 time points, varpsub= 
varp1[1:4]*****************************************/ 
 vp=diag(varpsub); print vp; 
/*Rows 1-3 are for days 3, 5, 7 of ID=1, Rows 4-6 for days 3, 5, 7 for 
ID=2, etc.*/ 
 create varp&label from vp; append from vp; print vp; 
/*xpx is the x'x matrix*/ 
 x = {1 3, 1 5, 1 7}; 
/************THIS MATRIX WILL NEED TO BE TAILORED TO SPECIFIC SAMPLING 
TIME POINTS***********/ 
 xpx=x`*x; 
 vbhat= inv(xpx)*x`;  
 vb2=vbhat*vp;  
 vb3=vb2*x;  
 vb4=vb3*inv(xpx); print vb4; 
 create vbhat&label from vb4; append from vb4; 
finish; 
run var(varp1, varpsub, vp, x, xpx, vbhat, vb2, vb3, vb4); quit; 
 
data s; 
set s (firstobs=&firstobs);  
/****The firstobs takes the (firstobs-1) observations into the data 
set***/ 
/****So if I want only the first three rows, firstobs=4***/ 
run; 
 
 %if i=1 %then %do; 
  data varps&label; set varp&label; run;  
  data vbhats&label; set vbhat&label; run;  
 %end; 
 %else %if i ne 1 %then %do; 
  proc datasets library=work nolist; append base=varps&label 
data=varp&label; run; quit; 
  proc datasets library=work nolist; append base=vbhats&label 
data=vbhat&label force; run; quit;  
 %end; 
/*Varps:  the variance matrices of Proportions concatenated on top each 
other 3x3*/ 
/*VBHats: the vbhat matrices concatenated on top each other 2x2 */ 
/******THE DIMENSIONS OF THIS WILL CHANGE BASED ON THE NUMBER OF TIME 
POINTS, ETC*********/ 
%put i;  
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%end; 
%mend; 
%var (sLR06v, 1002, 4, LR06); 
%var (sSEAv, 1002, 4, SEA); 
/* 
data chik.varpsLR06; set varpsLR06; run; 
data chik.vbhatsLR06; set vbhatsLR06; run; 
data chik.varpsSEA; set varpsSEA; run; 
data chik.vbhatsSEA; set vbhatsSEA; run; 
 
/***************************************************************/ 
/****************AREA CALCS = EVC ******************************/ 
/***************************************************************/ 
 
data varpsLR06; set chik.varpsLR06; run; 
data vbhatsLR06; set chik.vbhatsLR06; run; 
data varpsSEA; set chik.varpsSEA; run; 
data vbhatsSEA; set chik.vbhatsSEA; run; 
 
/***This dataset contains my linear rate of change for each set of time 
points (n=1001 bootstraps + original data) 
 Contains the following variables: strain, ID (of bootstrap/orig), 
intercept (of the linear relationship),  
           dpi (slope of 
the line, or rate of change)**********************************/ 
 
/***The way this macro works:  It reads the first observations for a 
set of data points then deletes those observations, 
   loops around to redo the macro for each ID (set of 
data points). 
    There is no identifier, so it will be imperative to sort over ID 
and know which set of obs in the output corresponds 




/***Seperated Data Sets: LR06r and SEAr****/ 
%sep (LR06r, reg, strain, "LR06"); 
%sep (SEAr, reg, strain, "SEA "); 
 
 
%macro area (b_data, vdata, n, firstobs, firstobsV, label, coef, 
intercept); 
/**********b_data is the data with the simulated linear relationship- 
regression estimates*******/ 
/********vdata is the data from the variance calculations above: 
vbhats_label from above********/ 
/*********n is the number of bootstraps plus original 
data*************************************/ 
/***********firstobs, firstobsV, see 
below****************************************************/ 
/***coef is the name of the variable in b_data that is the slope of the 
linear relationship**/ 
/*****intercept is the name of the variable in b_data corresponding to 
the intercept********/ 
/*****a is the day the integration 
starts**************************************************/ 
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proc sort data=&b_data; by ID; run; 
data b; set &b_data; drop strain ID; run; 
data v; set &vdata; run; 
 
%do i=1 %to &n %by 1;  
proc iml; 
start area (bs, c, bhat, bhatt, A, v, VAhat, vbhat); 
 use b; read all into bs var{&coef &intercept}; print bs; *Column 
one is int=B1, Column two is coef= B0; 
  bhat=bs[2:1]; bhatt=bhat`; print bhat; *row one in bhat is 
B0, row 2 is B1; 
  create bhat&label from bhatt; append from bhatt; 
 use c_matrix; read all into c var{area}; *row one is c0, row two 
is C1; print c; 
  A=c`*bhat; 
  create area_est&label from A; append from A; 
  
 
 /*use constants; read all into K var{const}; 
  Ahat=A*K; print Ahat; 
  create area_est&label from Ahat; append from Ahat;*/ 
 
 use v; read all into v var{COL1 COL2}; 
  vbhat=v[1:2, 1:2]; *gives me the first two rows of the 
matrix; 
  print vbhat;  
  VAhat=c`*vbhat*c; print VAhat; 
  *K2=k*k; 
  *VAhatc=VAhat*K2; *print VAhatc; 
  create varA_&label from VAhat; append from VAhat; 
finish area; run area(bs, c, bhat, bhatt, A, v, VAhat, vbhat); quit; 
 
data b; 
set b (firstobs=&firstobs);  
run; 
/******points to the firstobs=n 
observation****************************/ 




set v (firstobs=&firstobsV); 
/**The firstobsV value is based on the vbhat matrxi and is a 2x2 matrix 
for 2 parameter line, so firstobsV=3**/ 
run; 
 
%if i=1 %then %do; 
  data areas_est&label; set area_est&label; run;  
  data varAss_&label; set varA_&label; run;  
 %end; 
 %else %if i ne 1 %then %do; 
  proc datasets library=work nolist; append 
base=areas_est&label data=area_est&label force; run; quit; 
  proc datasets library=work nolist; append base=varAs_&label 
data=varA_&label force; run; quit;  
 %end; 
%put i; 
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%end; 
%mend; 
ods listing close; 
%area (LR06r, vbhatsLR06, 1002, 2, 3, LR06, dpi, intercept); 
%area (SEAr, vbhatsSEA, 1002, 2, 3, SEA, dpi, intercept); 
 
data chik.areas_estLR06; set areas_estLR06; run; 
data chik.varAs_LR06; set varAs_LR06; run; 
data chik.areas_estSEA; set areas_estSEA; run; 
data chik.varAs_SEA; set varAs_SEA; run; 
 
/********************Test*****************/ 
data areas_estLR06; set chik.areas_estLR06; run; 
data varsAs_LR06; set chik.varas_LR06; run; 
data areas_estSEA; set chik.areas_estSEA; run; 
data varAs_SEA; set chik.varAs_SEA; run; 
 
/********To Test, 
compute a t*-like statistics like so: 
 
    t*i=[Ahat(i,strainA) - 
Ahat(i,ref_strain)]/sqrt[(se(i,straiA))^2 + (se(i,ref_strain))^2] 
for i to J simulations (J=1001) 
 
Then get the cdf for t*i and get upper 97.5 and lower 0.025 quantiles 




do id=1 to 1002 by 1; 
output; 
put id; end; 
run; 
 
data areas_estLR06; merge chik.areas_estLR06 id; rename AreaA=AreaLR06; 
strain="LR06"; run; 
data areas_estSEA; merge chik.areas_estSEA id; rename COL1=AreaSEA; 
strain="SEA"; run; 
data varAs_LR06; merge chik.varAs_LR06 id; rename VarA=VarLR06;  
strain="LR06"; run; 
data varAs_SEA; merge chik.varAs_SEA id; rename COL1=VarSEA; 
strain="SEA"; run; 
 
proc sort data=areas_estLR06; by ID; run; 
proc sort data=VarAs_LR06; by ID; run; 
proc sort data=areas_estSEA; by ID; run; 
proc sort data=VarAs_SEA; by ID; run; 
 
/****Merging the LR06 and SEA data*****/ 
%macro merge (newdata, data1, dataRef, by); 
data &newdata;  
update &data1 &dataRef;  by &by; drop strain; run; 
%mend; 
%merge (comp, areas_estLR06, areas_estSEA, ID); 
%merge (compv, VarAs_LR06, VarAs_SEA, ID); 
%merge (compa, comp, compv, ID); 
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ods listing; 
/***tstar = [(area1(obs)- area1(boot) - (Area2(obs)- area2(boot)] / 
sqrt[(se1(boot)^2+se2(boot))^2]***/ 
%macro comp (data, REFid, COMPid, areaREF, areaComp); 
data &data; 
set &data; 
diffREF = (&areaREF-Area&REFid); *extant strain; 
diffComp= (&areaComp- Area&COMPid); *comparison strain; 
diff = diffREF - diffComp; 
denom= sqrt(Var&COMPid + Var&REFid); 
tstar= (diff-0) / denom; 
run; 
proc gchart data=&data; vbar tstar; run;quit; 
%mend; 
%comp (compa, LR06, SEA, 0.9518782407, 0.3840366709); 




/*  Using SAS INSIGHT to obtain: Solutions-->Analysis-->Interactive 
Data Analysis 
97.5 and 2.5 percentiles of T* will give us 95% confidence interval  
Compa: 97.5 = 2.6850 2.5 = .1009 
/************************/ 
/**********Building Confidence Intervals with the Original 
Data*************/ 
/***This assumes the first set of data is the origial, which it is 
here*****/ 
data compO; set compa; if ID=1 then output; run; 
 
%macro CI (datain, REFid, thi, tlow, COMPid); 
data &datain; 
set &datain; 
diff= (Area&COMPid - Area&REFid); 
sum=(Var&COMPid + Var&REFid); 
se=sqrt(sum); 
UCL= diff + (abs(&thi))*se; 
LCL= diff - (abs(&tlow))*se; 
run; 
%mend; 
%CI (compO, LR06, 2.6850, .1009, SEA); 
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Appendix	  4	  
	  
EVC	  and	  cVC	  SAS	  Code,	  Two	  Phase	  
	  
	  
/******************************EVC_cVC calculations with 2-Phases Part 
1**********************************/ 
/****This part of the program simulates all bootstrap data and 
calculates the linear function b(N)****/ 
/****The integration and EVC, cVC calculations are in Part2 ***/ 
 

















if strain="V" then output; 
run; 
 
/*THIS MACRO IS FOR BOOTSTRAPPING WITH PROC SURVEYSELECT, SELECTION 
WITH REPLACEMENT*/ 
/*Go me and my bad programming self*/ 
/*sx= sample size for timepoint=x)*/ 
%macro samp_wr (data, s1, s2, s3, s4, s5, s6, num); 
ods listing close; 
%do g=1 %to &num %by 1; 
 proc surveyselect data=&data outseed method=pps_wr sampsize=(&s1, 
&s2, &s3, &s4, &s5, &s6); 
 size n;  
 strata strain dpi; 






%samp_wr (LR, 20, 20, 20, 20, 20, 20, 1001); 
%samp_wr (pLR, 20, 20, 20, 20, 20, 20, 1001); 
 
/*COMBINE MACRO CREDIT:UCLA website- 
http://www.ats.ucla.edu/stat/SAS/code/mac_set.htm*/ 
/*Modified by me*/ 
%macro combine (id, start, stop); 
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data big&id; 
  set 
  %do i = &start %to &stop %by 1; 
    data&i 
  %end; 
  ; 
run; 
%mend; 
%combine (LR, 1, 1001); 




/*Double checking the data to make sure the surveyselect worked 
properly*/ 
/*InitialSeed is now the ID of each boostrap*/ 
/* AN ID=1 INDICATES ORIGINAL DATA SET*/ 
data big; set bigLR bigpLR; run; 
proc sort data=big; by strain dpi InitialSeed; run; 
proc means data=big sum; 
var NumberHits; 
by strain dpi InitialSeed; 
run; 
 
data biglr; set biglr; rename InitialSeed=ID; run; 
data bigpLR; set bigpLR; rename InitialSeed=ID; run; 
data Lr; set Lr; ID=1; run; 
data pLR; set pLR; ID=1; run; 
 
/*Getting the calculated vector comp. values = total positive legs/ 
total tested */ 
/*THIS IS DONE ON THE ORIGINAL DATA AS WELL AS BOOTSTRAPPED DATA*/ 
%macro b (data); 
proc sort data=&data; by dpi ID n; run; 
ods listing close; 
proc means data=&data; 
by dpi ID n; 
var diss; 















/*A NEW ID NEEDS TO BE ADDED TO THE BOOTSTRAPPED SAMPLES SO THAT THERE 
IS A SET OF IDs NOT JUST PER DPI*/ 
data NID; 
 do i=2 to 1002 by 1; 
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data NID3; set NID NID NID NID NID NID; run; 
 
%macro ID (data, original, new_data); 
data &data;  












set &data &original; 




%ID (sbiglr, slr, LR); 
%ID (sbigpLR, spLR, pLR); 
 
/*Need to seperate out the E-phase from the M-phase*/ 
/*Looking at the data, the delineation is around day 8 post exposure*/ 
/*So first set will be days 1-7, second set will be days 9 and 12*/ 
 
data Elr; strain="LR "; set Lr; if dpi <8 then output; run; 
data EpLR; strain="pLR"; set pLR; if dpi <8 then output;  run; 
data Mlr; strain="LR "; set Lr; if dpi >8 then output;  run; 
data MpLR; strain="pLR"; set pLR; if dpi >8 then output;  run; 
 
data chik.Elr; set Elr; run; 
data chik.EpLR; set Eplr; run; 
data chik.Mlr; set Mlr; run; 
data chik.MpLR; set Mplr; run; 
 
/*DOING REGRESSION TO GET THE LINEAR FUNCTION OF B(N)*/ 
/*THERE IS ONLY THE E-PHASE, SO ONLY 1 LINE IS NEEDED*/ 
%macro reg (data, id); 
ods listing close;  
proc sort data=&data; by ID; run; 
proc reg data=&data outest=reg&id; 
by ID; 
ID=ID; 
model b=dpi / cli;  
run; quit; 
%mend; 
%reg (ELR, ELR); 
%reg (MLR, MLR); 
%reg (EpLR, EpLR); 
%reg (MpLR, MpLR); 































set MrLR MrpLR; 
run; 
 
/**************************EVC_cVC calculations Part 2,  
       with 2 phases 
       E-
Phase******************************/ 
/****This part of the program performs the integration and EVC, cVC 
calculations***/ 
 
libname chik "C:\Users\ODP\Desktop\SCHOOL\papers\ChikV\Higgs"; 
 







proc sort data=reg; by strain ID dpi; run; 
 
/***dataset all has the simulated data for 1000 bootstraps with 
replacement + the original data***/ 
/***data has the following variables:  strain, ID (bootstrap ID), 
dpi (day post exposure),  
          n (at each 
dpi/strain), and b (dissemination rate)********/ 
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/***IMPORTANT to know which ID corresponds to the original experimental 
data, as this will need to be extracted 




/* COMPUTATION OF THE AREA UNDER THE CURVE: 
 
Area (Ahat) = (m(a^2)/-ln p) * integral(lower to upper) {p^N * b(N)} dN 
  = (m(a^2)/-ln p) * integral(lower to upper) {p^N * 
(beta1(N) + beta0)} dN 
  = (m(a^2)/-ln p) * [ beta1 * integral(lower to upper) {p^N 
* N} dN + beta0 integral(lower to upper) {p^N} dN] 
  = (m(a^2)/-ln p) * c0*Beta0 + c1*beta1 
Where 
  
 Bmatrix (Bhat)= (b0 b1)' = [(X'X)^-1 * X' * p-hat] 
 p-hat = [p1 p2 p3]'  where pi= proportion at time i 
 X=[1 t1 
       1 t2 
       1 ti]  where ti are the time points of interest 
    (t1 would be lower limit, ti would be upper 
limit of intergral) 
 
 c0 = integral(lower to upper) {p^N} dN = [1/(log p) ] * 
[p^N_upper bound - p^N_lower bound] 
 c1 = integral(lower to upper) {p^N * N} dN = [1/(log p)^2 * 
(p^N_upper * (N_upper* log p) - p^N_upper -  
            
 p^N_lower * (N_lower * log p) + p^N_lower)] 
 
*/ 
/*Using Trapezoidal Approximation for Area Under the Curve*/ 
/*Macro by Rebecca Christofferson*/ 
%macro auc (a, b, n, function, j); 
data is; 
cx= ((&b-&a)/&n); 
 do i = 0 to &n; 
 put i; output; 
 end; 




if i=0 then x=&a; 
 else if i=&n then x=&b; 





if i=0 then fx= (&function/2); 
 else if i=&n then fx= (&function/2);  
 else fx= (&function); 
run;  
 
proc sort data=x&j; by i; run; 
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proc sort data=fx&j; by i; run; 
 
data data&j; 




proc summary data=data&j; 
var fx; 













/******SINCE ALL IN THE SAME MOSQUITO VECTOR, DO NOT NEED STRAIN 
SPECIFIC QUANTITIES IN THIS PART********/ 
/******This is done on a per strain-ID basis******/ 
%auc (1, 7, 150, (.91**x), c0); 
%auc (1, 7, 150, ((.91**x)*x), c1); 
/***These give quantities of the two matrices above****/ 
 
data c_matrix; 
set areac0 areac1; 
run; 
 
/***Since I am holding constant m and a, arbitrarily assigned them a 
value of 1***/ 
/*** The daily survival probably .91 is from: 
  Harrington LC, Buonaccorsi JP, Edman JD, Costero A, 
Kittayapong P, et al. (2001)  
  Analysis of survival of young and old Aedes aegypti 
(Diptera: Culicidac) from  
  Puerto Rico and Thailand. J Med Entomol 38: 537-547. 
***/ 
data constants; 
input m a p; 
datalines; 
1 1 .91 
; 
run; 
data constants; set constants; const=m*(a**2)/ -(log(p)); run; 
 
/*********Estimates of the Variance**********/ 
/*  Variance (Ahat) = (constants^2) * (C0 C1)*Var(Bhat)*[(Co C1)'] 




 Variance (Bhat) = [(X'X)^-1]*X'*[diag(var p-hat-i)]*X*(X'X)^-1 
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where 
 var (p-hat-i) = [ p1(1-p1)/n1    0     0 
        0    p2(1-p2)/n2 
        0    0 
 pi(1-pi)/ni] 
 
*p has a binomial distribution; thus the binomial variances* 
***********************************************************************
********/ 
/*variance matrix calculations*/ 
proc sort data=chik; by strain ID dpi n; run; 
data m; set chik; 
var=b*(1-b)/N; *binomial variance computation where b=p; 
run; 
 
/*seperating each strain into its own dataset*/ 
%macro sep (dataset, set, var, condition); 
data &dataset; 
set &set; 




%sep (sLRv, m, strain, "LR "); 
%sep (spLRv, m, strain, "pLR"); 
 
%macro var (dataset, n, firstobs, label); 
data s; set &dataset; run; 
proc sort data=s; by ID dpi; run; 
%do i=1 %to &n %by 1; 
proc iml; 
/*reading my variances calculated in the data step above*/ 
/*vp is my variance of p, where p= my b values (proportions)*/ 
/*variances calculated as binomial p(1-p)/n */ 
start var(varp1, varpsub, vp, x, xpx, vbhat, vb2, vb3, vb4); 
 use s; read all into varp1 var{var}; create checkvp from varp1; 
append from varp1; 
 varpsub=varp1[1:4];  print varpsub; 
/***********The varpsub matrix will need to be changed if a different 
number of time points are used 
   EXAMPLE: for 4 time points, varpsub= 
varp1[1:4]*****************************************/ 
 vp=diag(varpsub); print vp; 
/*Rows 1-4 are for days 1, 3, 5, 7 of ID=1, Rows 5-8 for days 1, 3, 5, 
7 for ID=2, etc.*/ 
 create varp&label from vp; append from vp; print vp; 
/*xpx is the x'x matrix*/ 
 x = {1 1, 1 3, 1 5, 1 7}; 
/************THIS MATRIX WILL NEED TO BE TAILORED TO SPECIFIC SAMPLING 
TIME POINTS***********/ 
 xpx=x`*x; 
 vbhat= inv(xpx)*x`;  
 vb2=vbhat*vp;  
 vb3=vb2*x;  
 vb4=vb3*inv(xpx); print vb4; 
 create vbhat&label from vb4; append from vb4; 
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finish; 
run var(varp1, varpsub, vp, x, xpx, vbhat, vb2, vb3, vb4); quit; 
 
data s; 
set s (firstobs=&firstobs);  
/****The firstobs takes the (firstobs-1) observations into the data 
set***/ 
/****So if I want only the first three rows, firstobs=4***/ 
/****so for 4 time points, firstobs=5****/ 
run; 
 
 %if i=1 %then %do; 
  data varps&label; set varp&label; run;  
  data vbhats&label; set vbhat&label; run;  
 %end; 
 %else %if i ne 1 %then %do; 
  proc datasets library=work nolist; append base=varps&label 
data=varp&label; run; quit; 
  proc datasets library=work nolist; append base=vbhats&label 
data=vbhat&label force; run; quit;  
 %end; 
/*Varps:  the variance matrices of Proportions concatenated on top each 
other 3x3*/ 
/*VBHats: the vbhat matrices concatenated on top each other 2x2 */ 
/******THE DIMENSIONS OF THIS WILL CHANGE BASED ON THE NUMBER OF TIME 
POINTS, ETC*********/ 
%put i;  
%end; 
%mend; 
%var (sLRv, 1002, 5, LR); 
%var (splrv, 1002, 5, pLR); 
/* 
data chik.EvarpsLR; set varpsLR; run; 
data chik.EvbhatsLR; set vbhatsLR; run; 
data chik.EvarpspLR; set varpspLR; run; 
data chik.EvbhatspLR; set vbhatspLR; run; 
 
/***************************************************************/ 
/****************AREA CALCS = EVC ******************************/ 
/***************************************************************/ 
 
data varpsLR; set chik.EvarpsLR; run; 
data vbhatsLR; set chik.EvbhatsLR; run; 
data varpspLR; set chik.EvarpspLR; run; 
data vbhatspLR; set chik.EvbhatspLR; run; 
 
/***This dataset contains my linear rate of change for each set of time 
points (n=1001 bootstraps + original data) 
 Contains the following variables: strain, ID (of bootstrap/orig), 
intercept (of the linear relationship),  
           dpi (slope of 
the line, or rate of change)**********************************/ 
 
/***The way this macro works:  It reads the first observations for a 
set of data points then deletes those observations, 
   loops around to redo the macro for each ID (set of 
data points). 
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    There is no identifier, so it will be imperative to sort over ID 
and know which set of obs in the output corresponds 




/***Seperated Data Sets: LR06r and SEAr****/ 
%sep (LRr, reg, strain, "LR"); 
%sep (pLRr, reg, strain, "pLR "); 
 
 
%macro area (b_data, vdata, n, firstobs, firstobsV, label, coef, 
intercept); 
/**********b_data is the data with the simulated linear relationship- 
regression estimates*******/ 
/********vdata is the data from the variance calculations above: 
vbhats_label from above********/ 
/*********n is the number of bootstraps plus original 
data*************************************/ 
/***********firstobs, firstobsV, see 
below****************************************************/ 
/***coef is the name of the variable in b_data that is the slope of the 
linear relationship**/ 
/*****intercept is the name of the variable in b_data corresponding to 
the intercept********/ 
/*****a is the day the integration 
starts**************************************************/ 
proc sort data=&b_data; by ID; run; 
data b; set &b_data; drop strain ID; run; 
data v; set &vdata; run; 
 
%do i=1 %to &n %by 1;  
proc iml; 
start area (bs, c, bhat, bhatt, A, v, VAhat, vbhat); 
 use b; read all into bs var{&coef &intercept}; print bs; *Column 
one is int=B1, Column two is coef= B0; 
  bhat=bs[2:1]; bhatt=bhat`; print bhat; *row one in bhat is 
B0, row 2 is B1; 
  create bhat&label from bhatt; append from bhatt; 
 use c_matrix; read all into c var{area}; *row one is c0, row two 
is C1; print c; 
  A=c`*bhat; 
  create area_est&label from A; append from A; 
  
 
 /*use constants; read all into K var{const}; 
  Ahat=A*K; print Ahat; 
  create area_est&label from Ahat; append from Ahat;*/ 
 
 use v; read all into v var{COL1 COL2}; 
  vbhat=v[1:2, 1:2]; *gives me the first two rows of the 
matrix; 
  print vbhat;  
  VAhat=c`*vbhat*c; print VAhat; 
  *K2=k*k; 
  *VAhatc=VAhat*K2; *print VAhatc; 
  create varA_&label from VAhat; append from VAhat; 
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finish area; run area(bs, c, bhat, bhatt, A, v, VAhat, vbhat); quit; 
 
data b; 
set b (firstobs=&firstobs);  
run; 
/******points to the firstobs=n 
observation****************************/ 




set v (firstobs=&firstobsV); 
/**The firstobsV value is based on the vbhat matrxi and is a 2x2 matrix 
for 2 parameter line, so firstobsV=3**/ 
run; 
 
%if i=1 %then %do; 
  data areas_est&label; set area_est&label; run;  
  data varAss_&label; set varA_&label; run;  
 %end; 
 %else %if i ne 1 %then %do; 
  proc datasets library=work nolist; append 
base=areas_est&label data=area_est&label force; run; quit; 
  proc datasets library=work nolist; append base=varAs_&label 





ods listing close; 
%area (LRr, vbhatsLR, 1002, 2, 3, LR, dpi, intercept); 
%area (pLRr, vbhatspLR, 1002, 2, 3, pLR, dpi, intercept); 
 
data chik.Eareas_estLR; set areas_estLR; run; 
data chik.EvarAs_LR; set varAs_LR; run; 
data chik.Eareas_estpLR; set areas_estpLR; run; 
data chik.EvarAs_pLR; set varAs_pLR; run; 
 
/********************Test*****************/ 
data areas_estLR; set chik.Eareas_estLR; run; 
data varsAs_LR; set chik.Evaras_LR; run; 
data areas_estpLR; set chik.Eareas_estpLR; run; 
data varAs_pLR; set chik.EvarAs_pLR; run; 
 
/********To Test, 
compute a t*-like statistics like so: 
 
    t*i=[Ahat(i,strainA) - 
Ahat(i,ref_strain)]/sqrt[(se(i,straiA))^2 + (se(i,ref_strain))^2] 
for i to J simulations (J=1001) 
 
Then get the cdf for t*i and get upper 97.5 and lower 0.025 quantiles 




do id=1 to 1002 by 1; 
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output; 
put id; end; 
run; 
 
data areas_estLR; merge chik.areas_estLR id; rename COL1=AreaLR; 
strain="LR "; run; 
data areas_estpLR; merge chik.areas_estpLR id; rename COL1=AreapLR; 
strain="pLR"; run; 
data varAs_LR; merge chik.varAs_LR id; rename COL1=VarLR;  strain="LR 
"; run; 
data varAs_pLR; merge chik.varAs_pLR id; rename COL1=VarpLR; 
strain="pLR"; run; 
 
proc sort data=areas_estLR; by ID; run; 
proc sort data=VarAs_LR; by ID; run; 
proc sort data=areas_estpLR; by ID; run; 
proc sort data=VarAs_pLR; by ID; run; 
 
/****Merging the LR and pLR data*****/ 
%macro merge (newdata, data1, dataRef, by); 
data &newdata;  
update &data1 &dataRef;  by &by; drop strain; run; 
%mend; 
%merge (compE, areas_estLR, areas_estpLR, ID); 
%merge (compvE, VarAs_LR, VarAs_pLR, ID); 




/***tstar = [(area1(obs)- area1(boot) - (Area2(obs)- area2(boot)] / 
sqrt[(se1(boot)^2+se2(boot))^2]***/ 
%macro comp (data, REFid, COMPid, areaREF, areaComp);*REF=LR; 
data &data; 
set &data; 
diffREF = (&areaREF-Area&REFid); *extant strain; 
diffComp= (&areaComp- Area&COMPid); *comparison strain; 
diff = diffREF - diffComp; 
denom= sqrt(Var&COMPid + Var&REFid); 
tstar= (diff-0) / denom; 
run; 
proc gchart data=&data; vbar tstar; run;quit; 
%mend; 
%comp (compaE, LR, pLR, 1.4051738854, 1.8537182764); 
/*Values obtained from distribution analysis of tstar distribution*/ 
 
 
/**************************EVC_cVC calculations Part 2 
      With 2 phases 
      M-
Phase******************************/ 
/****This part of the program performs the integration and EVC, cVC 
calculations***/ 
 
libname chik "C:\Users\ODP\Desktop\SCHOOL\papers\ChikV\Higgs"; 
 
data chik; set chik.MLR chik.MpLR; run; 
 






proc sort data=reg; by strain ID dpi; run; 
 
/***dataset all has the simulated data for 1000 bootstraps with 
replacement + the original data***/ 
/***data has the following variables:  strain, ID (bootstrap ID), 
dpi (day post exposure),  
          n (at each 
dpi/strain), and b (dissemination rate)********/ 
/***IMPORTANT to know which ID corresponds to the original experimental 
data, as this will need to be extracted 




/* COMPUTATION OF THE AREA UNDER THE CURVE: 
 
Area (Ahat) = (m(a^2)/-ln p) * integral(lower to upper) {p^N * b(N)} dN 
  = (m(a^2)/-ln p) * integral(lower to upper) {p^N * 
(beta1(N) + beta0)} dN 
  = (m(a^2)/-ln p) * [ beta1 * integral(lower to upper) {p^N 
* N} dN + beta0 integral(lower to upper) {p^N} dN] 
  = (m(a^2)/-ln p) * c0*Beta0 + c1*beta1 
Where 
  
 Bmatrix (Bhat)= (b0 b1)' = [(X'X)^-1 * X' * p-hat] 
 p-hat = [p1 p2 p3]'  where pi= proportion at time i 
 X=[1 t1 
       1 t2 
       1 ti]  where ti are the time points of interest 
    (t1 would be lower limit, ti would be upper 
limit of intergral) 
 
 c0 = integral(lower to upper) {p^N} dN = [1/(log p) ] * 
[p^N_upper bound - p^N_lower bound] 
 c1 = integral(lower to upper) {p^N * N} dN = [1/(log p)^2 * 
(p^N_upper * (N_upper* log p) - p^N_upper -  
            
 p^N_lower * (N_lower * log p) + p^N_lower)] 
 
*/ 
/*Using Trapezoidal Approximation for Area Under the Curve*/ 
/*Macro by Rebecca Christofferson*/ 
%macro auc (a, b, n, function, j); 
data is; 
cx= ((&b-&a)/&n); 
 do i = 0 to &n; 
 put i; output; 
 end; 
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if i=0 then x=&a; 
 else if i=&n then x=&b; 





if i=0 then fx= (&function/2); 
 else if i=&n then fx= (&function/2);  
 else fx= (&function); 
run;  
 
proc sort data=x&j; by i; run; 
proc sort data=fx&j; by i; run; 
 
data data&j; 




proc summary data=data&j; 
var fx; 













/******SINCE ALL IN THE SAME MOSQUITO VECTOR, DO NOT NEED STRAIN 
SPECIFIC QUANTITIES IN THIS PART********/ 
/******This is done on a per strain-ID basis******/ 
%auc (9, 12, 150, (.91**x), c0); 
%auc (9, 12, 150, ((.91**x)*x), c1); 
/***These give quantities of the two matrices above****/ 
 
data c_matrix; 
set areac0 areac1; 
run; 
 
/***Since I am holding constant m and a, arbitrarily assigned them a 
value of 1***/ 
/*** The daily survival probably .91 is from: 
  Harrington LC, Buonaccorsi JP, Edman JD, Costero A, 
Kittayapong P, et al. (2001)  
  Analysis of survival of young and old Aedes aegypti 
(Diptera: Culicidac) from  
  Puerto Rico and Thailand. J Med Entomol 38: 537-547. 
***/ 
data constants; 
input m a p; 
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datalines; 
1 1 .91 
; 
run; 
data constants; set constants; const=m*(a**2)/ -(log(p)); run; 
 
/*********Estimates of the Variance**********/ 
/*  Variance (Ahat) = (constants^2) * (C0 C1)*Var(Bhat)*[(Co C1)'] 




 Variance (Bhat) = [(X'X)^-1]*X'*[diag(var p-hat-i)]*X*(X'X)^-1 
 
where 
 var (p-hat-i) = [ p1(1-p1)/n1    0     0 
        0    p2(1-p2)/n2 
        0    0 
 pi(1-pi)/ni] 
 
*p has a binomial distribution; thus the binomial variances* 
***********************************************************************
********/ 
/*variance matrix calculations*/ 
proc sort data=chik; by strain ID dpi n; run; 
data m; set chik; 
var=b*(1-b)/N; *binomial variance computation where b=p; 
run; 
 
/*seperating each strain into its own dataset*/ 
%macro sep (dataset, set, var, condition); 
data &dataset; 
set &set; 




%sep (sLRv, m, strain, "LR "); 
%sep (spLRv, m, strain, "pLR"); 
 
%macro var (dataset, n, firstobs, label); 
data s; set &dataset; run; 
proc sort data=s; by ID dpi; run; 
%do i=1 %to &n %by 1; 
proc iml; 
/*reading my variances calculated in the data step above*/ 
/*vp is my variance of p, where p= my b values (proportions)*/ 
/*variances calculated as binomial p(1-p)/n */ 
start var(varp1, varpsub, vp, x, xpx, vbhat, vb2, vb3, vb4); 
 use s; read all into varp1 var{var}; create checkvp from varp1; 
append from varp1; 
 varpsub=varp1[1:2];  print varpsub; 
/***********The varpsub matrix will need to be changed if a different 
number of time points are used 
   EXAMPLE: for 4 time points, varpsub= 
varp1[1:4]*****************************************/ 
 vp=diag(varpsub); print vp; 
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/*Rows 1-4 are for days 1, 3, 5, 7 of ID=1, Rows 5-8 for days 1, 3, 5, 
7 for ID=2, etc.*/ 
 create varp&label from vp; append from vp; print vp; 
/*xpx is the x'x matrix*/ 
 x = {1 9, 1 12}; 
/************THIS MATRIX WILL NEED TO BE TAILORED TO SPECIFIC SAMPLING 
TIME POINTS***********/ 
 xpx=x`*x; 
 vbhat= inv(xpx)*x`;  
 vb2=vbhat*vp;  
 vb3=vb2*x;  
 vb4=vb3*inv(xpx); print vb4; 
 create vbhat&label from vb4; append from vb4; 
finish; 
run var(varp1, varpsub, vp, x, xpx, vbhat, vb2, vb3, vb4); quit; 
 
data s; 
set s (firstobs=&firstobs);  
/****The firstobs takes the (firstobs-1) observations into the data 
set***/ 
/****So if I want only the first three rows, firstobs=4***/ 
/****so for 4 time points, firstobs=5****/ 
run; 
 
 %if i=1 %then %do; 
  data varps&label; set varp&label; run;  
  data vbhats&label; set vbhat&label; run;  
 %end; 
 %else %if i ne 1 %then %do; 
  proc datasets library=work nolist; append base=varps&label 
data=varp&label; run; quit; 
  proc datasets library=work nolist; append base=vbhats&label 
data=vbhat&label force; run; quit;  
 %end; 
/*Varps:  the variance matrices of Proportions concatenated on top each 
other 3x3*/ 
/*VBHats: the vbhat matrices concatenated on top each other 2x2 */ 
/******THE DIMENSIONS OF THIS WILL CHANGE BASED ON THE NUMBER OF TIME 
POINTS, ETC*********/ 
%put i;  
%end; 
%mend; 
%var (sLRv, 1002, 3, LR); 
%var (splrv, 1002, 3, pLR); 
/* 
data chik.MvarpsLR; set varpsLR; run; 
data chik.MvbhatsLR; set vbhatsLR; run; 
data chik.MvarpspLR; set varpspLR; run; 
data chik.MvbhatspLR; set vbhatspLR; run; 
 
/***************************************************************/ 
/****************AREA CALCS = EVC ******************************/ 
/***************************************************************/ 
 
data varpsLR; set chik.varpsLR; run; 
data vbhatsLR; set chik.vbhatsLR; run; 
data varpspLR; set chik.varpspLR; run; 
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data vbhatspLR; set chik.vbhatspLR; run; 
 
/***This dataset contains my linear rate of change for each set of time 
points (n=1001 bootstraps + original data) 
 Contains the following variables: strain, ID (of bootstrap/orig), 
intercept (of the linear relationship),  
           dpi (slope of 
the line, or rate of change)**********************************/ 
 
/***The way this macro works:  It reads the first observations for a 
set of data points then deletes those observations, 
   loops around to redo the macro for each ID (set of 
data points). 
    There is no identifier, so it will be imperative to sort over ID 
and know which set of obs in the output corresponds 




/***Seperated Data Sets: LR06r and SEAr****/ 
%sep (LRr, reg, strain, "LR"); 
%sep (pLRr, reg, strain, "pLR "); 
 
 
%macro area (b_data, vdata, n, firstobs, firstobsV, label, coef, 
intercept); 
/**********b_data is the data with the simulated linear relationship- 
regression estimates*******/ 
/********vdata is the data from the variance calculations above: 
vbhats_label from above********/ 
/*********n is the number of bootstraps plus original 
data*************************************/ 
/***********firstobs, firstobsV, see 
below****************************************************/ 
/***coef is the name of the variable in b_data that is the slope of the 
linear relationship**/ 
/*****intercept is the name of the variable in b_data corresponding to 
the intercept********/ 
/*****a is the day the integration 
starts**************************************************/ 
proc sort data=&b_data; by ID; run; 
data b; set &b_data; drop strain ID; run; 
data v; set &vdata; run; 
 
%do i=1 %to &n %by 1;  
proc iml; 
start area (bs, c, bhat, bhatt, A, v, VAhat, vbhat); 
 use b; read all into bs var{&coef &intercept}; print bs; *Column 
one is int=B1, Column two is coef= B0; 
  bhat=bs[2:1]; bhatt=bhat`; print bhat; *row one in bhat is 
B0, row 2 is B1; 
  create bhat&label from bhatt; append from bhatt; 
 use c_matrix; read all into c var{area}; *row one is c0, row two 
is C1; print c; 
  A=c`*bhat; 
  create area_est&label from A; append from A; 
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 /*use constants; read all into K var{const}; 
  Ahat=A*K; print Ahat; 
  create area_est&label from Ahat; append from Ahat;*/ 
 
 use v; read all into v var{COL1 COL2}; 
  vbhat=v[1:2, 1:2]; *gives me the first two rows of the 
matrix; 
  print vbhat;  
  VAhat=c`*vbhat*c; print VAhat; 
  *K2=k*k; 
  *VAhatc=VAhat*K2; *print VAhatc; 
  create varA_&label from VAhat; append from VAhat; 
finish area; run area(bs, c, bhat, bhatt, A, v, VAhat, vbhat); quit; 
 
data b; 
set b (firstobs=&firstobs);  
run; 
/******points to the firstobs=n 
observation****************************/ 




set v (firstobs=&firstobsV); 
/**The firstobsV value is based on the vbhat matrxi and is a 2x2 matrix 
for 2 parameter line, so firstobsV=3**/ 
run; 
 
%if i=1 %then %do; 
  data areas_est&label; set area_est&label; run;  
  data varAss_&label; set varA_&label; run;  
 %end; 
 %else %if i ne 1 %then %do; 
  proc datasets library=work nolist; append 
base=areas_est&label data=area_est&label force; run; quit; 
  proc datasets library=work nolist; append base=varAs_&label 





ods listing close; 
%area (LRr, vbhatsLR, 1002, 2, 3, LR, dpi, intercept); 
%area (pLRr, vbhatspLR, 1002, 2, 3, pLR, dpi, intercept); 
 
data chik.Mareas_estLR; set areas_estLR; run; 
data chik.MvarAs_LR; set varAs_LR; run; 
data chik.Mareas_estpLR; set areas_estpLR; run; 
data chik.MvarAs_pLR; set varAs_pLR; run; 
 
/********************Test*****************/ 
data areas_estLR; set chik.Mareas_estLR; run; 
data varsAs_LR; set chik.Mvaras_LR; run; 
data areas_estpLR; set chik.Mareas_estpLR; run; 
data varAs_pLR; set chik.MvarAs_pLR; run; 
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/********To Test, 
compute a t*-like statistics like so: 
 
    t*i=[Ahat(i,strainA) - 
Ahat(i,ref_strain)]/sqrt[(se(i,straiA))^2 + (se(i,ref_strain))^2] 
for i to J simulations (J=1001) 
 
Then get the cdf for t*i and get upper 97.5 and lower 0.025 quantiles 




do id=1 to 1002 by 1; 
output; 
put id; end; 
run; 
 
data areas_estLR; merge chik.areas_estLR id; rename COL1=AreaLR; 
strain="LR "; run; 
data areas_estpLR; merge chik.areas_estpLR id; rename COL1=AreapLR; 
strain="pLR"; run; 
data varAs_LR; merge chik.varAs_LR id; rename COL1=VarLR;  strain="LR 
"; run; 
data varAs_pLR; merge chik.varAs_pLR id; rename COL1=VarpLR; 
strain="pLR"; run; 
 
proc sort data=areas_estLR; by ID; run; 
proc sort data=VarAs_LR; by ID; run; 
proc sort data=areas_estpLR; by ID; run; 
proc sort data=VarAs_pLR; by ID; run; 
 
/****Merging the LR and pLR data*****/ 
%macro merge (newdata, data1, dataRef, by); 
data &newdata;  
update &data1 &dataRef;  by &by; drop strain; run; 
%mend; 
%merge (compE, areas_estLR, areas_estpLR, ID); 
%merge (compvE, VarAs_LR, VarAs_pLR, ID); 




/***tstar = [(area1(obs)- area1(boot) - (Area2(obs)- area2(boot)] / 
sqrt[(se1(boot)^2+se2(boot))^2]***/ 
%macro comp (data, REFid, COMPid, areaREF, areaComp);*REF=LR; 
data &data; 
set &data; 
diffREF = (&areaREF-Area&REFid); *extant strain; 
diffComp= (&areaComp- Area&COMPid); *comparison strain; 
diff = diffREF - diffComp; 
denom= sqrt(Var&COMPid + Var&REFid); 
tstar= (diff-0) / denom; 
run; 
proc gchart data=&data; vbar tstar; run;quit; 
%mend; 
%comp (compaE, LR, pLR, 1.0889, 1.06225); 
/*Values obtained from distribution analysis of tstar distribution*/ 




/*  Using SAS INSIGHT to obtain: Solutions-->Analysis-->Interactive 
Data Analysis 
97.5 and 2.5 percentiles of T* will give us 95% confidence interval  
Compa: 97.5 = 1.4017  2.5 = -1.2096 
/************************/ 
/**********Building Confidence Intervals with the Original 
Data*************/ 
/***This assumes the first set of data is the origial, which it is 
here*****/ 
data compO; set compaE; if ID=1 then output; run; 
 
%macro CI (datain, REFid, thi, tlow, COMPid); 
data &datain; 
set &datain; 
diff= (Area&COMPid - Area&REFid); 
sum=(Var&COMPid + Var&REFid); 
se=sqrt(sum); 
UCL= diff + (abs(&thi))*se; 
LCL= diff - (abs(&tlow))*se; 
run; 
%mend; 
%CI (compO, LR, 1.4017, -1.2096, pLR); 















EVC and cVC Detailed Calculations 
For strain i, the cumulative vectorial capacity (cVC) is the sum of the components of the 
exponential and M-phases:   
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Where ! is the effective vector competence (EVC) parameter. 
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S. Definition 2 
cVC then, is given by: 
!"#$!"#$%&%'()*  !!!"# + !"#$!!!!!"#    
S. Eq. 1 
 
To calculate variance estimates: 











  where Ni is the time value at sampled time point t 
S. Definition 5 
 




   where b is the observed proportion of disseminated infections at time t 
S. Definition 6 
 
Then for strain i at time points 1 to t: 








S. Definition 7 
 








  S. Eq. 2 
 
For Variance (E-phase + M-phase) 
a) Of EVC (without the inclusion of entomological constants) 
  
   = Var(E-phase) + Var(M-phase) 
 
b) Of cVC (with the inclusion of entomological constants) 
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